US20100216849A1 - Biphenylcarboxamides - Google Patents

Biphenylcarboxamides Download PDF

Info

Publication number
US20100216849A1
US20100216849A1 US12/771,285 US77128510A US2010216849A1 US 20100216849 A1 US20100216849 A1 US 20100216849A1 US 77128510 A US77128510 A US 77128510A US 2010216849 A1 US2010216849 A1 US 2010216849A1
Authority
US
United States
Prior art keywords
alkyl
formula
haloalkyl
halogen
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/771,285
Inventor
Ralf Dunkel
Hans-Ludwig Elbe
Heiko Rieck
Ulrike Wachendorff-Neumann
Peter Dahmen
Peter Lösel
Karl-Heinz Kuck
Astrid Mauler-Machnik
Jörg Nico Greul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/771,285 priority Critical patent/US20100216849A1/en
Publication of US20100216849A1 publication Critical patent/US20100216849A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A01N37/22—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof the nitrogen atom being directly attached to an aromatic ring system, e.g. anilides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/08—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with oxygen as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/10—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings with sulfur as the ring hetero atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A01N43/32—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • the present invention relates to novel biphenylcarboxamides, to a plurality of processes for their preparation and to their use for controlling unwanted microorganisms.
  • the compounds according to the invention can be present as mixtures of different possible isomeric forms, in particular of stereoisomers, such as, for example, E and Z, threo and erythro, and also optical isomers, and, if appropriate, also of tautomers.
  • stereoisomers such as, for example, E and Z, threo and erythro, and also optical isomers, and, if appropriate, also of tautomers.
  • E/Z isomers occur when R is C 1 -C 6 -alkyl. These isomers are generally present as a mixture.
  • the configuration given below in structural formulae always includes both possibilities. For the sake of simplicity, only one isomer is shown in each case.
  • novel biphenylcarboxamides of the formula (I) have very good microbicidal properties and can be used for controlling unwanted microorganisms both in crop protection and in the protection of materials.
  • the biphenylcarboxmides of the formula (I) according to the invention have considerably better fungicidal activity than the constitutionally most similar active compounds of the prior art having the same direction of action.
  • the formula (I) provides a general definition of the biphenylcarboxamides according to the invention.
  • X and Y independently of one another preferably represent fluorine, chlorine, bromine, cyano, nitro, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, C 1 -C 2 -haloalkyl, C 1 -C 2 -haloalkoxy or C 1 -C 2 -haloalkylthio having in each case 1 to 5 fluorine, chlorine and/or bromine atoms.
  • R 28 represents fluorine, chlorine, amino or methyl
  • R, Z, X, Y, m, n and A are as defined above. Suitable are in each case all combinations of the general, preferred, particularly preferred, very particularly preferred and especially preferred meanings mentioned above.
  • Preferred, particularly preferred, very particularly preferred and especially preferred are compounds which carry the substituents mentioned under preferred, particularly preferred, very particularly preferred and especially preferred, respectively.
  • Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl
  • alkyl or alkenyl can in each case be straight-chain or branched as far as this is possible, including in combination with heteroatoms, such as, for example, in alkoxy.
  • Optionally substituted radicals can be mono- or polysubstituted, where in the case of polysubstitution the substituents can be identical or different.
  • a plurality of radicals having the same indices, such as, for example, m radicals X for m>1, can be identical or different.
  • Halogen-substituted radicals such as, for example, haloalkyl
  • halogen-substituted radicals are mono- or polyhalogenated.
  • the halogen atoms can be identical or different.
  • halogen represents fluorine, chlorine, bromine and iodine, in particular fluorine, chlorine and bromine.
  • radical definitions or illustrations given above can also be combined with one another as desired, i.e. including combinations between the respective ranges and preferred ranges.
  • the definitions apply both to the end products and, correspondingly, to precursors and intermediates. Moreover, individual definitions may not apply.
  • the formula (II) provides a general definition of the carboxylic acid derivatives required as starting materials for carrying out the process (a) according to the invention.
  • A preferably has those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals.
  • G preferably represents chlorine, bromine, hydroxyl, methoxy or ethoxy, particularly preferably chlorine, hydroxyl or methoxy.
  • the carboxylic acid derivatives of the formula (II) are known or can be prepared by known processes (cf. WO 93/11 117, EP-A 0 545 099, EP-A 0 589 301 and EP-A 0 589 313).
  • the formula (III) provides a general definition of the aniline derivatives required as reaction components for carrying out the process (a) according to the invention.
  • R, Z, X, Y, m and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • aniline derivatives of the formula (III) are novel. Some of them can be prepared by known methods (cf. EP-A 0 545 099 and EP-A 0 589 301).
  • the formula (XI) provides a general definition of the 2-haloaniline derivatives required as reaction components for carrying out the processes (g) and (l) (see below) according to the invention.
  • X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • Hal preferably represents fluorine, chlorine or bromine, particularly preferably chlorine or bromine.
  • the 2-haloaniline derivatives of the formula (XI) are commercially available or can be prepared from the corresponding nitro compounds by reduction.
  • the formula (XII) provides a general definition of the anilineboronic acids required as reaction components for carrying out the processes (h) and (j) (see below) according to the invention.
  • X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • G 1 and G 2 preferably each represent hydrogen.
  • Anilineboronic acids of the formula (XII) are commercially available.
  • the formula (IV) provides a general definition of the carboxamide derivatives required as starting materials for carrying out the processes (b) and (f) according to the invention.
  • A, X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • the carboxamide derivatives of the formula (IV) are known or can be prepared by known processes (cf. WO 91/01311, EP-A 0 371 950).
  • the formula (V) provides a general definition of the boronic acid derivatives required for preparing the reaction components when carrying out the process (b) according to the invention and the process (g).
  • R, Z, Y and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • G 1 and G 2 preferably each represent hydrogen.
  • the boronic acid derivatives of the formula (V) are novel and can be prepared by
  • the formula (XIII) provides a general definition of the phenylboronic acids required as reaction components for carrying out the processes (i) and (l) (see below) according to the invention.
  • R, Y and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • G 1 and G 2 preferably each represent hydrogen.
  • the phenylboronic acids of the formula (XIII) are commercially available.
  • the formula (VI) provides a general definition of the carboxamide boronic acid derivatives required as reaction components for carrying out the process (c) according to the invention.
  • A, X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • G 1 and G 2 preferably each represent hydrogen or together represent tetramethylethylene.
  • the carboxamide boronic acid derivatives of the formula (VI) are novel. They can be prepared by
  • the formula (VII) provides a general definition of the phenyloxime derivatives required as reaction components for carrying out the processes (c) and (f) according to the invention and the process (h).
  • R, Z, Y and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • the phenyloxime derivatives of the formula (VII) are known and/or can be prepared by known processes (cf. Synth. Commun 2000, 30, 665-669, Synth. Commun 1999, 29, 1697-1701).
  • the formula (VIII) provides a general definition of the biphenylacyl derivatives required as starting materials for carrying out the process (d) according to the invention.
  • A, R, X, Y, m and n have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • the biphenylacyl derivatives of the formula (VIII) are novel. They can be prepared by
  • the formula (XIV) provides a general definition of the 2-benzaldehydeaniline derivatives required as reaction components for carrying out the process (k) according to the invention.
  • R, X, Y, m and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • the 2-benzaldehydeaniline derivatives of the formula (XIV) are novel. They can be prepared by
  • the formula (IX) provides a general definition of the hydroxylamine derivatives required as reaction components for carrying out the process (d) according to the invention and the process (i).
  • Z preferably has those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for this radical. Preference is given to using the hydrochlorides mentioned in the description. However, it is also possible to use the free hydroxylamine derivatives in the process according to the invention.
  • Hydroxylamine derivatives of the formula (IX) are commercially available.
  • the formula (I-a) provides a general definition of the hydroxyimino derivatives required as starting materials for carrying out the process (e) according to the invention.
  • A, R, X, Y, m and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • hydroxyimino derivatives of the formula (I-a) according to the invention can be prepared by one of the processes (a), (b), (c), (d) or (f) according to the invention described above.
  • the formula (X) provides a general definition of the compounds required as reaction components for carrying out the process (e) according to the invention.
  • Z preferably has those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for this radical.
  • E preferably represents chlorine, bromine, iodine, methanesulfonyl or p-toluenesulfonyl.
  • E particularly preferably represents chlorine or bromine.
  • Suitable acid binders for carrying out the processes (a), (b), (c), (d), (e) and (f) according to the invention are in each case all inorganic and organic bases customary for such reactions.
  • alkaline earth metal or alkali metal hydroxides such as sodium hydroxide, calcium hydroxide, potassium hydroxide, or else ammonium hydroxide
  • alkali metal carbonates such as sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate
  • alkali metal or alkaline earth metal acetates such as sodium acetate, potassium acetate, calcium acetate
  • tertiary amines such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, pyridine, N-methylpiperidine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicyclo
  • Suitable diluents for carrying out the processes (a), (b), (c), (d), (e) and (f) according to the invention are in each case all customary inert organic solvents.
  • reaction temperatures can in each case be varied within a relatively wide range.
  • the processes are carried out at temperatures between 0° C. and 140° C., preferably between 10° C. and 120° C.
  • the active compounds are suitable for protecting plants and plant organs, increasing harvest yields, improving the quality of the harvested material and controlling animal pests, in particular insects, arachnids and nematodes, which are encountered in agriculture, in forests, in gardens and in leisure facilities, in the protection of stored products and of materials, and in the hygiene sector and they are tolerated well by plants, have favorable homeotherm toxicity and good environmental compatibility. They may preferably be employed as crop protection agents. They are active against normally sensitive and resistant species and against all or some stages of development.
  • the abovementioned pests include:
  • Isopoda for example, Oniscus asellus, Armadillidium vulgare and Porcellio scaber.
  • Chilopoda for example, Geophilus carpophagus and Scutigera spp.
  • Symphyla for example, Scutigerella immaculata.
  • Thysanura for example, Lepisma saccharina.
  • Orthoptera From the order of the Orthoptera, for example, Acheta domesticus, Gryllotalpa spp., Locusta migratoria migratorioides, Melanoplus spp. and Schistocerca gregaria.
  • Phthiraptera From the order of the Phthiraptera, for example, Pediculus humanus corporis, Haematopinus spp., Linognathus spp., Trichodectes spp. and Damalinia spp.
  • Thysanoptera From the order of the Thysanoptera, for example, Hercinothrips femoralis, Thrips tabaci, Thrips palmi and Franidiniella accidentalis.
  • From the order of the Homoptera for example, Aleurodes brassicae, Bemisia tabaci, Trialeurodes vaporariorum, Aphis gossypii, Brevicoryne brassicae, Cryptomyzus ribis, Aphis fabae, Aphis pomi, Eriosoma lanigerum, Hyalopterus arundinis, Phylloxera vastatrix, Pemphigus spp., Macrosiphum avenae, Myzus spp., Phorodon humuli, Rhopalosiphum padi, Empoasca spp., Euscelis bilobatus, Nephotettix cincticeps, Lecanium corni, Saissetia oleae, Laodelphax striatellus, Nilaparvata lugens, Aonidiella aurantii, Aspidiotus hederae, Pseu
  • Hymenoptera From the order of the Hymenoptera, for example, Diprion spp., Hoplocampa spp., Lasius spp., Monomorium pharaonis and Vespa spp.
  • Scorpio maurus Latrodectus mactans, Acarus siro, Argas spp., Ornithodoros spp., Dermanyssus gallinae, Eriophyes ribis, Phyllocoptruta oleivora, Boophilus spp., Rhipicephalus spp., Amblyomma spp., Hyalomma spp., Ixodes spp., Psoroptes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa, Panonychus spp., Tetranychus spp., Hemitarsonemus spp. and Brevipalpus spp.
  • the phytoparasitic nematodes include, for example, Pratylenchus spp., Radopholus similis, Ditylenchus dipsaci, Tylenchulus semipenetrans, Heterodera spp., Globodera spp., Meloidogyne spp., Aphelenchoides spp., Longidorus spp., Xiphinema spp., Trichodorus spp., Bursaphelenchus spp.
  • the compounds according to the invention have potent microbicidal activity and can be employed for controlling undesirable microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials.
  • Fungicides can be employed in crop protection for controlling Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.
  • Bactericides can be employed in crop protection for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
  • Xanthomonas species such as, for example, Xanthomonas campestris pv. oryzae;
  • Pseudomonas species such as, for example, Pseudomonas syringae pv. lachrymans;
  • Erwinia species such as, for example, Erwinia amylovora;
  • Pythium species such as, for example, Pythium ultimum
  • Phytophthora species such as, for example, Phytophthora infestans
  • Pseudoperonospora species such as, for example, Pseudoperonospora humuli or Pseudoperonospora cubensis;
  • Plasmopara species such as, for example, Plasmopara viticola
  • Bremia species such as, for example, Bremia lactucae
  • Peronospora species such as, for example, Peronospora pisi or P. brassicae;
  • Erysiphe species such as, for example, Erysiphe graminis
  • Sphaerotheca species such as, for example, Sphaerotheca fuliginea
  • Podosphaera species such as, for example, Podosphaera leucotricha
  • Venturia species such as, for example, Venturia inaequalis
  • Pyrenophora species such as, for example, Pyrenophora teres or P. graminea (conidia form: Drechslera , syn: Helminthosporium );
  • Cochliobolus species such as, for example, Cochliobolus sativus (conidia form: Drechslera , syn: Helminthosporium );
  • Uromyces species such as, for example, Uromyces appendiculatus
  • Puccinia species such as, for example, Puccinia recondita
  • Sclerotinia species such as, for example, Sclerotinia sclerotiorum
  • Tilletia species such as, for example, Tilletia caries
  • Ustilago species such as, for example, Ustilago nuda or Ustilago avenae;
  • Pellicularia species such as, for example, Pellicularia sasakii;
  • Pyricularia species such as, for example, Pyricularia oryzae
  • Fusarium species such as, for example, Fusarium culmorum
  • Botrytis species such as, for example, Botrytis cinerea
  • Septoria species such as, for example, Septoria nodorum
  • Leptosphaeria species such as, for example, Leptosphaeria nodorum;
  • Cercospora species such as, for example, Cercospora canescens
  • Alternaria species such as, for example, Alternaria brassicae ;
  • Pseudocercosporella species such as, for example, Pseudocercosporella herpotrichoides.
  • the active compounds according to the invention also have very good fortifying action in plants. Accordingly, they can be used for mobilizing the defences of the plant against attack by undesirable microorganisms.
  • plant-fortifying (resistance-inducing) substances are to be understood as meaning those substances which are capable of stimulating the defence system of plants such that, when the treated plants are subsequently inoculated with undesirable microorganisms, they show substantial resistance to these microorganisms.
  • undesirable microorganisms are to be understood as meaning phytopathogenic fungi, bacteria and viruses.
  • the substances according to the invention can be used to protect plants for a certain period after the treatment against attack by the pathogens mentioned.
  • the period for which protection is provided generally extends over 1 to 10 days, preferably 1 to 7 days, after the treatment of the plants with the active compounds.
  • the active compounds according to the invention can be used with particularly good results for controlling diseases in viticulture and in the cultivation of fruit and vegetables, such as, for example, against Venturia, Botrytis, Sclerotina, Rhizoctonia, Uncinula, Sphaerotheca, Podosphaera, Alternaria and Colletotrichum species.
  • Rice diseases such as Pyricularia and Pellicularia species, are likewise controlled with good results.
  • the active compounds according to the invention are also suitable for increasing the yield of crops. In addition, they show reduced toxicity and are well tolerated by plants.
  • the active compounds according to the invention can also be used as herbicides, for influencing plant growth and for controlling animal pests. If appropriate, they can also be used as intermediates and precursors for the synthesis of further active compounds.
  • Plants are to be understood as meaning in the present context all plants and plant populations such as desired and undesired wild plants or crop plants (including naturally occurring crop plants).
  • Crop plants can be plants which can be obtained by conventional plant breeding and optimization methods or by biotechnological and recombinant methods or by combinations of these methods, including the transgenic plants and inclusive of the plant cultivars protectable or not protectable by plant breeders' rights.
  • Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, examples which may be mentioned being leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes.
  • the plant parts also include harvested material, and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds.
  • Treatment according to the invention of the plants and plant parts with the active compounds is carried out directly or by allowing the compounds to act on the surroundings, environment or storage space by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on, injection, and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats.
  • the substances according to the invention can be employed for protecting industrial materials against infection with, and destruction by, undesired microorganisms.
  • Industrial materials in the present context are understood as meaning non-living materials which have been prepared for use in industry.
  • industrial materials which are intended to be protected by active compounds according to the invention from microbial change or destruction can be adhesives, sizes, paper and board, textiles, leather, wood, paints and plastic articles, cooling lubricants and other materials which can be infected with, or destroyed by, microorganisms.
  • Parts of production plants, for example cooling-water circuits, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected.
  • Industrial materials which may be mentioned within the scope of the present invention are preferably adhesives, sizes, paper and board, leather, wood, paints, cooling lubricants and heat-transfer liquids, particularly preferably wood.
  • Microorganisms capable of degrading or changing the industrial materials are, for example, bacteria, fungi, yeasts, algae and slime organisms.
  • the active compounds according to the invention preferably act against fungi, in particular molds, wood-discoloring and wood-destroying fungi (Basidiomycetes), and against slime organisms and algae.
  • Alternaria such as Alternaria tenuis
  • Aspergillus such as Aspergillus niger
  • Chaetomium such as Chaetomium globosum
  • Coniophora such as Coniophora puetana
  • Lentinus such as Lentinus tigrinus
  • Penicillium such as Penicillium glaucum
  • Polyporus such as Polyporus versicolor
  • Aureobasidium such as Aureobasidium pullulans
  • Sclerophoma such as Sclerophoma pityophila
  • Trichoderma such as Trichoderma viride
  • Escherichia such as Escherichia coli
  • Pseudomonas such as Pseudomonas aeruginosa
  • Pseudomonas aeruginosa Pseudomonas
  • Staphylococcus such as Staphylococcus aureus.
  • the active compounds can be converted to the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microencapsulations in polymeric substances and in coating compositions for seeds, and ULV cool and warm fogging formulations.
  • customary formulations such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microencapsulations in polymeric substances and in coating compositions for seeds, and ULV cool and warm fogging formulations.
  • formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is, liquid solvents, liquefied gases under pressure, and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants, and/or foam formers. If the extender used is water, it is also possible to employ, for example, organic solvents as auxiliary solvents.
  • extenders that is, liquid solvents, liquefied gases under pressure, and/or solid carriers
  • surfactants that is emulsifiers and/or dispersants, and/or foam formers.
  • the extender used is water, it is also possible to employ, for example, organic solvents as auxiliary solvents.
  • suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, alcohols such as butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide or dimethyl sulfoxide, or else water.
  • aromatics such as xylene, toluene or alkylnaphthalenes
  • chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride
  • aliphatic hydrocarbons such as cyclohe
  • Liquefied gaseous extenders or carriers are to be understood as meaning liquids which are gaseous at standard temperature and under atmospheric pressure, for example aerosol propellants such as halogenated hydrocarbons, or else butane, propane, nitrogen and carbon dioxide.
  • Suitable solid carriers are: for example ground natural minerals such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals such as finely divided silica, alumina and silicates.
  • Suitable solid carriers for granules are: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, or else synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks.
  • Suitable emulsifiers and/or foam formers are: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates, or else protein hydrolysates.
  • Suitable dispersants are: for example lignosulphite waste liquors and methylcellulose.
  • Tackifiers such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids such as cephalins and lecithins and synthetic phospholipids can be used in the formulations.
  • Other possible additives are mineral and vegetable oils.
  • colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • inorganic pigments for example iron oxide, titanium oxide and Prussian Blue
  • organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs
  • trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • the formulations generally comprise between 0.1 and 95 percent by weight of active compound, preferably between 0.5 and 90%.
  • the active compounds according to the invention can be used as such or in their formulations, also in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, to broaden, for example, the activity spectrum or to prevent development of resistance. In many cases, synergistic effects are obtained, i.e. the activity of the mixture is greater than the activity of the individual components.
  • Suitable mixing components are the following compounds:
  • bronopol dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulfate and other copper preparations.
  • the compounds of the formula (I) according to the invention also have very good antimycotic activity. They have a very broad antimycotic activity spectrum in particular against dermatophytes and yeasts, moulds and diphasic fungi (for example against Candida species, such as Candida albicans, Candida glabrata ), and Epidermophyton floccosum, Aspergillus species, such as Aspergillus niger and Aspergillus fumigatus, Trichophyton species, such as Trichophyton mentagrophytes, Microsporon species such as Microsporon canis and audouinii .
  • the list of these fungi by no means limits the mycotic spectrum covered, but is only for illustration.
  • the active compounds can be used as such, in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules.
  • Application is carried out in a customary manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming, spreading, etc. It is furthermore possible to apply the active compounds by the ultra-low-volume method, or to inject the active compound preparation or the active compound itself into the soil. It is also possible to treat the seeds of the plants.
  • the application rates can be varied within a relatively wide range, depending on the kind of application.
  • the active compound application rates are generally between 0.1 and 10 000 g/ha, preferably between 10 and 1000 g/ha.
  • the active compound application rates are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 10 g per kilogram of seed.
  • the active compound application rates are generally between 0.1 and 10 000 g/ha, preferably between 1 and 5000 g/ha.
  • compositions used for protecting industrial materials generally comprise the active compounds in an amount of from 1 to 95%, preferably from 10 to 75%.
  • the application concentrations of the active compounds according to the invention depend on the nature and the occurrence of the microorganisms to be controlled and on the composition of the material to be protected. The optimum amount for application can be determined by test series. In general, the application concentrations are in the range from 0.001 to 5% by weight, preferably from 0.05 to 1.0% by weight, based on the material to be protected.
  • the activity and the activity spectrum of the active compounds to be used according to the invention in the protection of materials, or of the compositions, concentrates or, quite generally, formulations preparable therefrom, can be increased, if appropriate, by addition of further antimicrobially active compounds, fungicides, bactericides, herbicides, insectizides or other active compounds for widening the activity spectrum or obtaining special effects such as, for example, additional protection against insects. These mixtures may have a wider activity spectrum than the compounds according to the invention.
  • the active compounds according to the invention can furthermore be present in the form of a mixture with synergists.
  • Synergists are compounds by which the activity of the active compounds is increased without it being necessary for the synergist added to be active itself.
  • the active compounds according to the invention can furthermore be present in the form of a mixture with inhibitors which reduce the degradation of the active compound after application in the habitat of the plant, on the surface of parts of plants or in plant tissues.
  • the active compound content of the use forms prepared from the commercially available formulations can vary within broad ranges.
  • the active compound concentration of the use forms can be from 0.0000001 up to 95% by weight of active compound, preferably between 0.0001 and 1% by weight.
  • the active compound When used against hygiene pests and pests of stored products, the active compound is distinguished by excellent residual action on wood and clay as well as good stability to alkali on limed substrates.
  • Plants which are treated particularly preferably in accordance with the invention are those of the plant cultivars which are in each case commercially available or in use. Plant cultivars are understood as meaning plants with new traits which have been bred either by conventional breeding, by mutagenesis or by recombinant DNA techniques. They may take the form of cultivars, biotypes and genotypes.
  • the treatment according to the invention may also result in superadditive (“synergistic”) effects.
  • superadditive for example, reduced application rates and/or a widened activity spectrum and/or an increase in the activity of the substances and compositions which can be used in accordance with the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to salinity in the water or soil, increased flowering performance, facilitated harvesting, accelerated maturation, higher yields, higher quality and/or better nutritional value of the harvested products, better storage characteristics and/or processability of the harvested products are possible which exceed the effects which were actually to be expected.
  • the preferred transgenic plants or plant cultivars to be treated in accordance with the invention include all those plants which, owing to the process of recombinant modification, were given genetic material which confers particular, advantageous, valuable traits to these plants. Examples of such properties are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to salinity in the water or soil, increased flowering performance, facilitated harvesting, accelerated maturation, higher yields, higher quality and/or higher nutritional value of the harvested products, better storage characteristics and/or better processability of the harvested products.
  • transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice), maize, soybeans, potato, cotton, tobacco, oilseed rape and fruit plants (with the fruits apples, pears, citrus fruits and grapes), with particular emphasis on maize, soybeans, potatoes, cotton, tobacco, and oilseed rape.
  • Traits which are especially emphasized are the increased defence of the plants against insects, arachnids, nematodes, and slugs and snails owing to toxins being formed in the plants, in particular toxins which are generated in the plants by the genetic material of Bacillus thuringiensis (for example by the genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CryIF and their combinations; hereinbelow “Bt plants”).
  • SAR systemic acquired resistance
  • PAT phosphinotricin
  • Bt plants are maize cultivars, cotton cultivars, soybean cultivars and potato cultivars which are commercially available under the trade names YIELD GARD® (for example maize, cotton, soybean), KnockOut® (for example maize), StarLink® (for example maize), Bollgard® (cotton), Nucotn® (cotton) and NewLeaf® (potato).
  • YIELD GARD® for example maize, cotton, soybean
  • KnockOut® for example maize
  • StarLink® for example maize
  • Bollgard® cotton
  • Nucotn® cotton
  • NewLeaf® potato
  • herbicide-tolerant plants examples include maize cultivars, cotton cultivars and soybean cultivars which are commercially available under the trade names Roundup Ready® (tolerance to glyphosate, for example maize, cotton, soybean), Liberty Link® (tolerance to phosphinotricin, for example oilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance to sulfonylureas, for example maize)
  • Herbicide-resistant plants plants bred in a conventional manner for herbicide tolerance
  • Clearfield® for example maize
  • the plants listed can be treated particularly advantageously according to the invention with the compounds of the general formula (I) or the active compound mixtures according to the invention.
  • the preferred ranges stated above for the active compounds and mixtures also apply to the treatment of these plants. Particular emphasis may be given to the treatment of plants with the compounds or mixtures specifically mentioned in the present text.
  • reaction mixture is cooled to room temperature and washed twice with in each case 80 ml of water, and the organic phase is dried over magnesium sulfate and then concentrated under reduced pressure.
  • the residue is purified by silica gel column chromatography (hexane/methyl tert-butyl ether 3:1).
  • the mixture is cooled to room temperature and extracted twice with in each case 50 ml of diethyl ether.
  • the organic phases are washed with water, dried over sodium sulfate and concentrated under reduced pressure.
  • the residue is purified by silica gel column chromatography (hexane/methyl tert-butyl ether 3:1).
  • biphenylcarboxamides of the formula (I-1) listed in the table below are likewise prepared according to Examples 1 to 5 and according to the general process descriptions and methods.
  • the residue is purified by silica gel column chromatography (cyclohexane/ethyl acetate 3:1).
  • the lambda-max values were determined in the maxima of the chromatographic signals using the UV spectra from 200 nm to 400 nm
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvents and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • the plants are then placed in a greenhouse at about 21° C. and a relative atmospheric humidity of about 90%.
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvents and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
  • active compound 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • the plants are then placed in a greenhouse at a temperature of about 20° C. and a relative atmospheric humidity of 80% to promote the development of rust pustules.
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
  • Solvents 100 parts by weight of acetone
  • a stated amount of the preparation of active compound of the desired concentration is pipetted onto a standardized amount of synthetic feed. After the methanol has evaporated, about 200-300 eggs of the diamond back moth ( Plutella xylostella ) are placed onto the feed.
  • the kill of the eggs in % is determined 100% means that all animals have been killed; 0% means that none of the animals have been killed.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

This invention relates to novel biphenylcarboxamides of the formula (I)
Figure US20100216849A1-20100826-C00001
    • in which R, Z, X, Y, m, n and A are as defined in the disclosure, to a plurality of processes for preparing these compounds and their use for controlling unwanted microorganisms, and to novel intermediates and their preparation.

Description

  • The present invention relates to novel biphenylcarboxamides, to a plurality of processes for their preparation and to their use for controlling unwanted microorganisms.
  • It is already known that numerous carboxanilides have fungicidal properties (compare WO 93/11 117, WO 99/09 013, WO 00/14 071, EP-A 0 545 099 and EP-A 0 589 301). In particular, WO 02/08195 and WO 02/08197 disclose oxyiminomethyl-substituted carboxamides. The activity of these compounds is good; however, it is sometimes unsatisfactory.
  • This invention now provides novel biphenylcarboxamides of the formula (I)
  • Figure US20100216849A1-20100826-C00002
    • in which
    • R represents hydrogen, C1-C6-alkyl or C1-C3-haloalkyl having in each case 1 to 7 fluorine, chlorine and/or bromine atoms,
    • Z represents C3-C8-alkenyl, C3-C8-alkynyl, C3-C8-haloalkenyl, C3-C8-haloalkynyl having in each case 1 to 5 fluorine, chlorine and/or bromine atoms, or (C3-C8-cycloalkyl)(C1-C4-alkyl),
    • X and Y independently of one another represent halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, C1-C8-alkylthio, C1-C6-haloalkyl, C1-C6-haloalkoxy or C1-C6-haloalkylthio having in each case 1 to 13 fluorine, chlorine and/or bromine atoms,
    • m represents 0, 1, 2, 3 or 4, where x represents identical or different radicals if m represents 2, 3 or 4,
    • n represents 0, 1, 2, 3 or 4, where y represents identical or different radicals if n represents 2, 3 or 4,
    • and
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00003
      • in which
      • R1 represents hydrogen, cyano, halogen, nitro, C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, aminocarbonyl, aminocarbonyl-C1-C4-alkyl or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, C1-C4-haloalkylthio having in each case 1 to 5 halogen atoms, and
      • R2 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy or C1-C4-alkylthio and
      • R3 represents hydrogen, C1-C4-alkyl, hydroxy-C1-C4-alkyl, C2-C6-alkenyl, C3-C6-cycloalkyl, C1-C4-alkylthio-C1-C4-alkyl, C1-C4-alkoxy-C1-C4-alkyl, or represents C1-C4-haloalkyl, halo(C1-C4-alkylthio-C halo(C1-C4-alkoxy-C1-C4-alkyl) having in each case 1 to 5 halogen atoms or represents phenyl,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00004
      • in which
      • R4 and R5 independently of one another represent hydrogen, halogen, C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms and
      • R6 represents halogen, cyano or C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-haloalkoxy having in each case 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00005
      • in which
      • R7 and R8 independently of one another represent hydrogen, halogen, C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms and
      • R9 represents hydrogen, halogen or C1-C4-alkyl,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00006
      • in which
      • R10 represents hydrogen, halogen, hydroxyl, cyano, C1-C6-alkyl, C1-C4-haloalkyl, C1-C4-haloalkoxy, C1-C4-haloalkylthio having in each case 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00007
      • in which
      • R11 represents halogen, hydroxyl, cyano, C1-C4 alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-haloalkyl, C1-C4-haloalkoxy, C1-C4-haloalkylthio having in each case 1 to 5 halogen atoms and
      • R12 represents hydrogen, halogen, cyano, C1-C4 alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfinyl, C1-C4-alkylsulfonyl or represents C1-C4-haloalkyl, C1-C4-haloalkoxy having in each case 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00008
      • in which
      • R13 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
      • R14 represents C1-C4-alkyl,
      • X1 represents S (sulfur), represents SO, SO2 or CH2 and
      • p represents 0, 1 or 2,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00009
      • in which
      • R15 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00010
      • in which
      • R16 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00011
      • in which
      • R16 represents halogen, cyano, C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, represents hydrogen, halogen, C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
      • R19 represents hydrogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl having 1 to 5 halogen atoms, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkysulfonyl, di(C1-C4-alkyl)aminosulfonyl, C1-C6-alkylcarbonyl or represents optionally substituted phenylsulfonyl or benzoyl,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00012
      • in which
      • R20 and R21 independently of one another represent hydrogen, halogen, amino, C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms and
      • R22 represents hydrogen, halogen, C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
        or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00013
      • in which
      • R23 and R24 independently of one another represent hydrogen, halogen, amino, nitro, C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms and
      • R25 represents hydrogen, halogen, C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
        or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00014
      • in which
      • R26 represents hydrogen, halogen, amino, C1-C4-alkylamino, di-(C1-C4-alkyl)amino, cyano, C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms and
      • R27 represents halogen, C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms,
        or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00015
      • in which
      • R28 represents hydrogen, halogen, amino, C1-C4-alkylamino, di-(C1-C4-alkyl)amino, cyano, C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms and
      • R29 represents halogen, C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00016
      • in which
      • R30 represents halogen, C1-C4-alkyl, C1-C4-haloalkyl having 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00017
      • in which
      • R31 represents hydrogen or C1-C4-alkyl and
      • R32 represents halogen or C1-C4-alkyl,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00018
      • in which
      • R33 represents C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms,
    • or
    • A represents a radical of the formula
  • Figure US20100216849A1-20100826-C00019
      • in which
      • R34 represents hydrogen, halogen, C1-C4-alkyl or C1-C2-haloalkyl having 1 to 5 halogen atoms.
  • If appropriate, the compounds according to the invention can be present as mixtures of different possible isomeric forms, in particular of stereoisomers, such as, for example, E and Z, threo and erythro, and also optical isomers, and, if appropriate, also of tautomers. What is claimed are both the E and the Z isomers, and the threo and erytho-, and also the optical isomers, any mixtures of these isomers, and also the possible tautomeric forms.
  • In particular with reference to the oxime double bond, E/Z isomers occur when R is C1-C6-alkyl. These isomers are generally present as a mixture. The configuration given below in structural formulae always includes both possibilities. For the sake of simplicity, only one isomer is shown in each case.
  • Furthermore, it has been found that biphenylcarboxamides of the formula (I) are obtained when
    • a) carboxylic acid derivatives of the formula (II)
  • Figure US20100216849A1-20100826-C00020
      • in which
      • A is as defined above and
      • G represents halogen, hydroxyl or C1-C6-alkoxy
      • are reacted with aniline derivatives of the formula (III)
  • Figure US20100216849A1-20100826-C00021
      • in which
      • R, Z, X, Y, m and n are as defined above,
      • if appropriate in the presence of a catalyst, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent,
    • or
    • b) carboxamide derivatives of the formula (IV)
  • Figure US20100216849A1-20100826-C00022
      • in which
      • A, X and m are as defined above,
      • Hal1 represents bromine or iodine,
      • are reacted with boronic acid derivatives of the formula (V)
  • Figure US20100216849A1-20100826-C00023
      • in which
      • R, Z, Y and n are as defined above and
      • G1 and G2 each represent hydrogen or together represent tetramethylethylene in the presence of a catalyst, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent,
    • Or
    • c) carboxamide boronic acid derivatives of the formula (VI)
  • Figure US20100216849A1-20100826-C00024
      • in which
      • A, X and m are as defined above and
      • G1 and G2 each represent hydrogen or together represent tetramethylethylene
      • are reacted with phenyl oxime derivatives of the formula (VII)
  • Figure US20100216849A1-20100826-C00025
      • in which
      • R, Z, Y and n are as defined above, Hal1 represents bromine or iodine,
      • in the presence of a catalyst, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent,
    • or
    • d) biphenylacyl derivatives of the formula (VIII)
  • Figure US20100216849A1-20100826-C00026
      • in which
      • A, R, X, Y, m and n are as defined above,
      • are reacted with hydroxylamine derivatives of the formula (IX)

  • Z—O—NH2×HCl  (IX)
      • in which
      • Z is as defined above,
      • if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent,
    • or
    • e) hydroxyimino derivatives of the formula (I-a)
  • Figure US20100216849A1-20100826-C00027
      • in which
      • A, R, X, Y, m and n are as defined above
      • are reacted with compounds of the formula (X)

  • Z-E  (X)
      • in which
      • Z is as defined above,
      • E represents chlorine, bromine, iodine, methanesulfonyl or p-toluenesulfonyl,
      • if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent,
    • or
    • f) carboxamide derivatives of the formula (IV)
  • Figure US20100216849A1-20100826-C00028
      • in which
      • A, X and m are as defined above,
      • Hal1 represents bromine or iodine,
      • are reacted with phenyl oxime derivatives of the formula (VII)
  • Figure US20100216849A1-20100826-C00029
      • in which
      • R, Z, Y and n are as defined above,
      • Hal1 represents bromine or iodine
      • in the presence of a palladium or platinum catalyst and in the presence of 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bis-1,3,2-dioxaborolane, if appropriate in the presence of an acid binder and if appropriate in the presence of a diluent.
  • Finally, it has been found that novel biphenylcarboxamides of the formula (I) have very good microbicidal properties and can be used for controlling unwanted microorganisms both in crop protection and in the protection of materials.
  • Surprisingly, the biphenylcarboxmides of the formula (I) according to the invention have considerably better fungicidal activity than the constitutionally most similar active compounds of the prior art having the same direction of action.
  • The formula (I) provides a general definition of the biphenylcarboxamides according to the invention.
    • R preferably represents hydrogen, C1-C4-alkyl or C1-C3-haloalkyl having in each case 1 to 7 fluorine, chlorine and/or bromine atoms.
    • Z preferably represents C3-C6-alkenyl, C3-C6-alkynyl, C3-C6-haloalkenyl, C3-C6-haloalkynyl having in each case 1 to 5 fluorine, chlorine and/or bromine atoms, or (C3-C6-cycloalkyl)-(C1-C4-alkyl).
  • X and Y independently of one another preferably represent fluorine, chlorine, bromine, cyano, nitro, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C1-C2-haloalkyl, C1-C2-haloalkoxy or C1-C2-haloalkylthio having in each case 1 to 5 fluorine, chlorine and/or bromine atoms.
    • m preferably represents 0, 1, 2 or 3, where x represents identical or different radicals if m represents 2 or 3.
    • n preferably represents 0, 1, 2 or 3, where y represents identical or different radicals if n represents 2 or 3.
    • A preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00030
      • in which
      • R1 represents hydrogen, cyano, fluorine, chlorine, bromine, iodine, methyl, ethyl, isopropyl, cyclopropyl, methoxy, ethoxy, methylthio, ethylthio, aminocarbonyl, aminocarbonylmethyl, aminocarbonylethyl, C1-C2-haloalkyl C1-C2-haloalkoxy having in each case 1 to 5 fluorine, chlorine and/or bromine atoms, trifluoromethylthio or difluoromethylthio,
      • R2 represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, methoxy, ethoxy, methylthio or ethylthio and
      • R3 represents hydrogen, methyl, ethyl, n-propyl, isopropyl, hydroxymethyl, hydroxyethyl, cyclopropyl, cyclopentyl, cyclohexyl, C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms or represents phenyl.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00031
      • in which
      • R4 and R5 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R6 represents fluorine, chlorine, bromine, iodine, cyano, methyl, ethyl, trifluoromethyl or C1-C2-haloalkoxy having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00032
      • in which
      • R7 and R8 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R9 represents hydrogen, fluorine, chlorine, bromine, methyl or ethyl.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00033
      • in which
      • R10 represents hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, C1-C1-C2-haloalkyl, C1-C2-haloalkoxy, C1-C2-haloalkylthio having in each case 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00034
      • in which
      • R11 represents fluorine, chlorine, bromine, iodine, hydroxyl, cyano, C1-C4-alkyl, methoxy, ethoxy, methylthio, ethylthio, C1-C2-haloalkyl, C1-C2-haloalkoxy having in each case 1 to 5 fluorine, chlorine and/or bromine atoms, trifluoromethylthio, difluoromethylthio and
      • R12 represents hydrogen, fluorine, chlorine, bromine, iodine, cyano, C1-C4-alkyl, methoxy, ethoxy, methylthio, ethylthio, C1-C2-alkylsulfinyl, C1-C2-alkylsulfonyl, C1-C2-haloalkyl, C1-C2-haloalkoxy having in each case 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00035
      • in which
      • R13 represents methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R14 represents methyl or ethyl,
      • X1 represents S (sulfur), represents SO, SO2 or CH2 and
      • p represents 0, 1 or 2.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00036
      • in which
      • R15 represents methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00037
      • in which
      • R16 represents methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00038
      • in which
      • R17 represents fluorine, chlorine, bromine, cyano, methyl, ethyl, isopropyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms,
      • R18 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R19 represents hydrogen, methyl, ethyl, C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms, C1-C2-alkoxy-C1-C2-alkyl, hydroxymethyl, hydroxyethyl, methylsulfonyl or dimethylaminosulfonyl.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00039
      • in which
      • R20 and R21 independently of one another represent hydrogen, fluorine, chlorine, bromine, amino, methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R22 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00040
      • in which
      • R23 and R24 independently of one another represent hydrogen, fluorine, chlorine, bromine, amino, nitro, methyl, ethyl or represent C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R25 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00041
      • in which
      • R26 represents hydrogen, fluorine, chlorine, bromine, amino, C1-C4-alkylamino, di-(C1-C4-alkyl)amino, cyano, methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R27 represents fluorine, chlorine, bromine, methyl, ethyl or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00042
      • in which
      • R28 represents hydrogen, fluorine, chlorine, bromine, amino, C1-C4-alkylamino, di-(C1-C4-alkyl)amino, cyano, methyl, ethyl or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms and
      • R29 represents fluorine, chlorine, bromine, methyl, ethyl or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00043
      • in which
      • R30 represents fluorine, chlorine, bromine, methyl, ethyl or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00044
      • in which
      • R31 represents hydrogen, methyl or ethyl and
      • R32 represents fluorine, chlorine, bromine, methyl or ethyl.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00045
      • in which
      • R33 represents methyl, ethyl or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine and/or bromine atoms.
    • A furthermore preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00046
      • in which
      • R34 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or trifluoromethyl.
    • R particularly preferably represents hydrogen, methyl, ethyl, isopropyl, tert-butyl.
    • Z particularly preferably represents allyl, 2-butenyl, 2-methylallyl, 1-methylallyl, 3-methyl-2-butenyl, propargyl, 2-butynyl, 3-butynyl, 2-methyl-3-butynyl, 3,3-difluoroallyl, 3,3-dichloroallyl, cyclopropylmethyl, cyclopentylmethyl, cyclohexylmethyl.
    • X and Y independently of one another particularly preferably represent fluorine, chlorine, bromine, cyano, nitro, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, methoxy, ethoxy, methylthio, trichloromethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, difluoromethoxy, trifluoromethoxy, trifluoromethylthio, difluorochloromethylthio,
    • m particularly preferably represents 0 or 1.
    • n particularly preferably represents 0, 1 or 2, where y represents identical or different radicals if n represents 2.
    • A particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00047
      • in which
      • R1 represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, isopropyl, cyclopropyl, methoxy, ethoxy, methylthio, ethylthio, monofluoromethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, trichloromethoxy, trifluoromethylthio or difluoromethylthio and
      • R2 represents hydrogen, fluorine, chlorine, bromine, iodine, methyl, ethyl, methoxy, ethoxy, methylthio or ethylthio and
      • R3 represents hydrogen, methyl, ethyl, hydroxymethyl, hydroxyethyl, trifluoromethyl, difluoromethyl or phenyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00048
      • in which
      • R4 and R5 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl or trichloromethyl and
      • R6 represents fluorine, chlorine, bromine, cyano, methyl, trifluoromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy or trichloromethoxy.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00049
      • in which
      • R7 and R8 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl or trichloromethyl and
      • R9 represents hydrogen, fluorine, chlorine, bromine, methyl or ethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00050
      • in which
      • R10 represents hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, difluoromethyl, trifluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, trichloromethoxy, trifluoromethylthio, difluoromethylthio, difluorochloromethylthio or trichloromethylthio.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00051
      • in which
      • R11 represents fluorine, chlorine, bromine, iodine, hydroxyl, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, methoxy, ethoxy, methylthio, ethylthio, trifluoromethyl, difluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, trichloromethoxy, difluoromethylthio, trifluoromethylthio and
      • R12 represents hydrogen, fluorine, chlorine, bromine, iodine, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, methoxy, ethoxy, methylthio, ethylthio, methylsulfinyl, methylsulfonyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy or trichloromethoxy.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00052
      • in which
      • R13 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl and
      • R14 represents methyl or ethyl,
      • X1 represents S (sulfur), represents SO, SO2 or CH2 and
      • p represents 0, 1 or 2.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00053
      • in which
      • R15 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00054
      • in which
      • R16 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00055
      • in which
      • R17 represents fluorine, chlorine, bromine, cyano, methyl, ethyl, isopropyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl,
      • R18 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl or trichloromethyl and
      • R19 represents hydrogen, methyl, ethyl, trifluoromethyl, methoxymethyl, ethoxymethyl, hydroxymethyl or hydroxyethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00056
      • in which
      • R20 and R21 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl and
      • R22 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00057
      • in which
      • R23 and R24 independently of one another represent hydrogen, fluorine, chlorine, bromine, nitro, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl and
      • R25 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00058
      • in which
      • R26 represents hydrogen, fluorine, chlorine, bromine, amino, methylamino, dimethylamino, cyano, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl and
      • R27 represents fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00059
      • in which
      • R28 represents hydrogen, fluorine, chlorine, bromine, amino, methylamino, dimethylamino, cyano, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl and
      • R29 represents fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00060
      • in which
      • R30 represents fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00061
      • in which
      • R31 represents hydrogen, methyl or ethyl and
      • R32 represents fluorine, chlorine, bromine, methyl or ethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00062
      • in which
      • R33 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl or trichloromethyl.
    • A furthermore particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00063
      • in which
      • R34 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl or trifluoromethyl.
    • R very particularly preferably represents hydrogen or methyl.
    • Z very particularly preferably represents allyl, 2-butenyl, 2-methylallyl, 1-methylallyl, 3-methyl-2-butenyl, propargyl, 2-butynyl, 2-methyl-3-butynyl, 3,3-difluoroallyl, cyclopropylmethyl.
    • X very particularly preferably represents fluorine or methyl.
    • Y very particularly preferably represents fluorine, chlorine, bromine, cyano, methyl, methoxy, methylthio, trichloromethyl, trifluoromethyl, trifluoromethoxy, trifluoromethylthio.
    • m very particularly preferably represents 0 or 1.
    • n very particularly preferably represents 0 or 1.
    • A very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00064
      • in which
      • R1 represents fluorine, chlorine, bromine, iodine, methyl, isopropyl, cyclopropyl, monofluoromethyl, difluoromethyl or trifluoromethyl and
      • R2 represents hydrogen, fluorine, chlorine or methyl and
      • R3 represents methyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00065
      • in which
      • R4 and R5 independently of one another represent hydrogen, fluorine or methyl and
      • R6 represents methyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00066
      • in which
      • R7 and R8 independently of one another represent hydrogen, fluorine or methyl and
      • R9 represents methyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00067
      • in which
      • R10 represents iodine, methyl, difluoromethyl or trifluoromethyl,
      • R10 furthermore represents chlorine or bromine
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00068
      • in which
      • R11 represents fluorine, chlorine, bromine, methyl or trifluoromethyl and
      • R12 represents hydrogen.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00069
      • in which
      • R13 represents methyl or trifluoromethyl and
      • R14 represents methyl,
      • X1 represents S (sulfur) or CH2 and
      • p represents 0 or 1.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00070
      • in which
      • R15 represents methyl, trifluoromethyl or difluoromethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00071
      • in which
      • R16 represents methyl, trifluoromethyl or difluoromethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00072
      • in which
      • R17 represents fluorine, methyl or trifluoromethyl,
      • R18 represents hydrogen or methyl and
      • R19 represents methyl or methoxymethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00073
      • in which
      • R20 and R21 independently of one another represent hydrogen, fluorine or methyl and
      • R22 represents methyl or trifluoromethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00074
      • in which
      • R23 and R24 independently of one another represent hydrogen, fluorine or methyl and
      • R25 represents methyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00075
      • in which
      • R26 represents fluorine, chlorine, amino or methyl and
      • R27 represents chlorine, methyl, trifluoromethyl or difluoromethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00076
      • in which
  • R28 represents fluorine, chlorine, amino or methyl and
      • R29 represents chlorine, methyl, trifluoromethyl or difluoromethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00077
      • in which
      • R30 represents chlorine, methyl, trifluoromethyl or difluoromethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00078
      • in which
      • R31 represents methyl and
      • R32 represents chlorine or methyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00079
      • in which
      • R33 represents methyl, trifluoromethyl or difluoromethyl.
    • A furthermore very particularly preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00080
      • in which
      • R34 represents hydrogen, chlorine or methyl.
    • R especially preferably represents hydrogen or methyl.
    • Z especially preferably represents allyl, 2-methyl-allyl, 1-methyl-allyl, 3-methyl-2-butenyl, propargyl, 2-butynyl, 3,3-difluoroallyl, cyclopropylmethyl.
    • X especially preferably represents fluorine.
    • m especially preferably represents 0 or 1.
    • n especially preferably represents 0.
    • A especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00081
      • in which
      • R1 represents methyl, monofluoromethyl, difluoromethyl or trifluoromethyl and
      • R2 represents hydrogen, fluorine, chlorine or methyl and
      • R3 represents methyl.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00082
      • in which
      • R4 and R5 each represent hydrogen and
      • R6 represents methyl.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00083
      • in which
      • R10 represents iodine, methyl or trifluoromethyl.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00084
      • in which
      • R11 represents chlorine or trifluoromethyl and
      • R12 represents hydrogen.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00085
      • in which
      • R13 represents methyl or trifluoromethyl and
      • X1 represents S (sulfur) and
      • p represents 0.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00086
      • in which
      • R17 represents methyl or trifluoromethyl,
      • R18 represents hydrogen or methyl and
      • R19 represents methyl.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00087
      • in which
      • R20 and R21 each represent hydrogen and
      • R22 represents methyl.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00088
      • in which
      • R26 represents amino or methyl and
      • R27 represents methyl, trifluoromethyl or difluoromethyl.
    • A furthermore especially preferably represents a radical of the formula
  • Figure US20100216849A1-20100826-C00089
      • in which
      • R33 represents methyl.
  • Preference is furthermore given to compounds of the formula (I-1)
  • Figure US20100216849A1-20100826-C00090
  • in which
    R, Z, X, Y, m, n and A are as defined above. Suitable are in each case all combinations of the general, preferred, particularly preferred, very particularly preferred and especially preferred meanings mentioned above.
  • Particular preference is given to compounds of the formula (I-1) in which X is fluorine and m is 0 or 1.
  • Particular preference is given to compounds of the formula (I-1) in which n is 0.
  • Particular preference is given to compounds of the formula (I-1) in which R is hydrogen or methyl.
  • Particular preference is furthermore given to compounds of the formula (I) in which X is fluorine and m is 0 or 1.
  • Particular preference is furthermore given to compounds of the formula (I) in which n is 0.
  • Particular preference is furthermore given to compounds of the formula (I) in which R is hydrogen or methyl.
  • Preferred, particularly preferred, very particularly preferred and especially preferred are compounds which carry the substituents mentioned under preferred, particularly preferred, very particularly preferred and especially preferred, respectively.
  • Saturated or unsaturated hydrocarbon radicals, such as alkyl or alkenyl, can in each case be straight-chain or branched as far as this is possible, including in combination with heteroatoms, such as, for example, in alkoxy.
  • Optionally substituted radicals can be mono- or polysubstituted, where in the case of polysubstitution the substituents can be identical or different. A plurality of radicals having the same indices, such as, for example, m radicals X for m>1, can be identical or different.
  • Halogen-substituted radicals, such as, for example, haloalkyl, are mono- or polyhalogenated. In the case of polyhalogenation, the halogen atoms can be identical or different. Here, halogen represents fluorine, chlorine, bromine and iodine, in particular fluorine, chlorine and bromine.
  • However, the general or preferred radical definitions or illustrations given above can also be combined with one another as desired, i.e. including combinations between the respective ranges and preferred ranges. The definitions apply both to the end products and, correspondingly, to precursors and intermediates. Moreover, individual definitions may not apply.
  • Using 5-fluoro-1,3-dimethyl-1H-pyrazole-4-carbonyl chloride and 1-(2′-aminobiphenyl-4-yl)ethanone O-allyl oxime as starting materials, the course of the process (a) according to the invention can be illustrated by the formula scheme below.
  • Figure US20100216849A1-20100826-C00091
  • Using N-(2-iodophenyl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide and 4-[1-(allyloxyimino)ethyl]phenylboronic acid as starting materials and a catalyst, the course of the process (b) according to the invention can be illustrated by the following scheme below.
  • Figure US20100216849A1-20100826-C00092
  • Using 2-[(5-fluoro-1,3-dimethylpyrazol-4-yl)carbonylamino]phenylboronic acid and 1-(4-bromophenyl)ethanone O-allyl oxime as starting materials and a catalyst, the course of the process (c) according to the invention can be illustrated by the formula scheme below.
  • Figure US20100216849A1-20100826-C00093
  • Using N-(4′-acetylbiphenyl-2-yl)-2-chloronicotinamide and O-(3,3-dichloroallyl)hydroxyl-amine hydrochloride as starting materials, the course of the process (d) according to the invention can be illustrated by the formula scheme below.
  • Figure US20100216849A1-20100826-C00094
  • Using N-(4′-{1-[hydroxyimino]ethyl}biphenyl-2-yl) 1,3-dimethyl-1H-pyrazole-4-carboxamide and 1,1,3-trichloropropene as starting materials, the course of the process (e) according to the invention can be illustrated by the formula scheme below.
  • Figure US20100216849A1-20100826-C00095
  • Using N-(2-bromophenyl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide and 1-(4-bromophenyl)ethanone O-allyl oxime as starting materials and a catalyst and 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bis-1,3,2-dioxaborolane, the course of the process (f) according to the invention can be illustrated by the formula scheme below.
  • Figure US20100216849A1-20100826-C00096
    • Illustration of the Processes and Intermediates
  • The formula (II) provides a general definition of the carboxylic acid derivatives required as starting materials for carrying out the process (a) according to the invention. In this formula, A preferably has those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals. G preferably represents chlorine, bromine, hydroxyl, methoxy or ethoxy, particularly preferably chlorine, hydroxyl or methoxy.
  • The carboxylic acid derivatives of the formula (II) are known or can be prepared by known processes (cf. WO 93/11 117, EP-A 0 545 099, EP-A 0 589 301 and EP-A 0 589 313).
  • The formula (III) provides a general definition of the aniline derivatives required as reaction components for carrying out the process (a) according to the invention. In this formula, R, Z, X, Y, m and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • The aniline derivatives of the formula (III) are novel. Some of them can be prepared by known methods (cf. EP-A 0 545 099 and EP-A 0 589 301).
  • Aniline derivatives of the formula (III) are furthermore obtained when
    • g) 2-haloaniline derivatives of the general formula (XI)
  • Figure US20100216849A1-20100826-C00097
      • in which
      • X and m are as defined above and
      • Hal2 represents halogen are reacted with boronic acid derivatives of the formula (V)
  • Figure US20100216849A1-20100826-C00098
      • in which R, Z, Y, n, G1 and G2 are as defined above,
      • if appropriate in the presence of an acid binder, if appropriate in the presence of an inert organic diluent and if appropriate in the presence of catalyst, or
    • h) anilineboronic acids of the formula (XII)
  • Figure US20100216849A1-20100826-C00099
      • in which X, m, G1 and G2 are as defined above
      • are reacted with phenyloxime derivatives of the formula (VII)
  • Figure US20100216849A1-20100826-C00100
      • in which R, Z, Y, n and Hal1 are as defined above,
      • if appropriate in the presence of an acid binder, if appropriate in the presence of an inert organic diluent and if appropriate in the presence of a catalyst.
  • The formula (XI) provides a general definition of the 2-haloaniline derivatives required as reaction components for carrying out the processes (g) and (l) (see below) according to the invention. In this formula, X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices. Hal preferably represents fluorine, chlorine or bromine, particularly preferably chlorine or bromine.
  • The 2-haloaniline derivatives of the formula (XI) are commercially available or can be prepared from the corresponding nitro compounds by reduction.
  • The formula (XII) provides a general definition of the anilineboronic acids required as reaction components for carrying out the processes (h) and (j) (see below) according to the invention. In this formula, X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices. G1 and G2 preferably each represent hydrogen.
  • Anilineboronic acids of the formula (XII) are commercially available.
  • The formula (IV) provides a general definition of the carboxamide derivatives required as starting materials for carrying out the processes (b) and (f) according to the invention. In this formula, A, X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • The carboxamide derivatives of the formula (IV) are known or can be prepared by known processes (cf. WO 91/01311, EP-A 0 371 950).
  • The formula (V) provides a general definition of the boronic acid derivatives required for preparing the reaction components when carrying out the process (b) according to the invention and the process (g). In this formula, R, Z, Y and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices. G1 and G2 preferably each represent hydrogen.
  • The boronic acid derivatives of the formula (V) are novel and can be prepared by
    • i) reacting phenylboronic acids of the formula (XIII)
  • Figure US20100216849A1-20100826-C00101
    Z—O—NH2×HCl  (IX)
      • in which Z is as defined above,
      • if appropriate in the presence of an acid binder, if appropriate in the presence of an inert organic diluent and if appropriate in the presence of a catalyst.
  • The formula (XIII) provides a general definition of the phenylboronic acids required as reaction components for carrying out the processes (i) and (l) (see below) according to the invention. In this formula, R, Y and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices. G1 and G2 preferably each represent hydrogen.
  • The phenylboronic acids of the formula (XIII) are commercially available.
  • The formula (VI) provides a general definition of the carboxamide boronic acid derivatives required as reaction components for carrying out the process (c) according to the invention. In this formula, A, X and m preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices. G1 and G2 preferably each represent hydrogen or together represent tetramethylethylene.
  • The carboxamide boronic acid derivatives of the formula (VI) are novel. They can be prepared by
    • j) reacting carboxylic acid derivatives of the formula (II)
  • Figure US20100216849A1-20100826-C00102
      • in which A and G are as defined above
      • with anilineboronic acids of the formula (XII)
  • Figure US20100216849A1-20100826-C00103
      • in which X, m, G1 and G2 are as defined above,
      • if appropriate in the presence of an acid binder, if appropriate in the presence of an inert organic diluent and if appropriate in the presence of a catalyst.
  • The formula (VII) provides a general definition of the phenyloxime derivatives required as reaction components for carrying out the processes (c) and (f) according to the invention and the process (h). In this formula, R, Z, Y and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • The phenyloxime derivatives of the formula (VII) are known and/or can be prepared by known processes (cf. Synth. Commun 2000, 30, 665-669, Synth. Commun 1999, 29, 1697-1701).
  • The formula (VIII) provides a general definition of the biphenylacyl derivatives required as starting materials for carrying out the process (d) according to the invention. In this formula, A, R, X, Y, m and n have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • The biphenylacyl derivatives of the formula (VIII) are novel. They can be prepared by
    • k) reacting carboxylic acid derivatives of the formula (II)
  • Figure US20100216849A1-20100826-C00104
      • in which A and G are as defined above
      • with 2-benzaldehydeaniline derivatives of the formula (XIV)
  • Figure US20100216849A1-20100826-C00105
      • in which R, X, Y, m and n are as defined above,
      • if appropriate in the presence of an acid binder and if appropriate in the presence of an inert organic diluent.
  • The formula (XIV) provides a general definition of the 2-benzaldehydeaniline derivatives required as reaction components for carrying out the process (k) according to the invention. In this formula, R, X, Y, m and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • The 2-benzaldehydeaniline derivatives of the formula (XIV) are novel. They can be prepared by
    • l) reacting aniline derivatives of the formula (XI)
  • Figure US20100216849A1-20100826-C00106
      • in which X, m and Hal2 are as defined above and
      • with phenylboronic acid derivatives of the formula (XIII)
  • Figure US20100216849A1-20100826-C00107
      • in which R, Y, n, G1 and G2 are as defined above,
      • if appropriate in the presence of an acid binder and if appropriate in the presence of an inert organic diluent.
  • The formula (IX) provides a general definition of the hydroxylamine derivatives required as reaction components for carrying out the process (d) according to the invention and the process (i). In this formula, Z preferably has those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for this radical. Preference is given to using the hydrochlorides mentioned in the description. However, it is also possible to use the free hydroxylamine derivatives in the process according to the invention.
  • Hydroxylamine derivatives of the formula (IX) are commercially available.
  • The formula (I-a) provides a general definition of the hydroxyimino derivatives required as starting materials for carrying out the process (e) according to the invention. In this formula, A, R, X, Y, m and n preferably have those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for these radicals or these indices.
  • The hydroxyimino derivatives of the formula (I-a) according to the invention can be prepared by one of the processes (a), (b), (c), (d) or (f) according to the invention described above.
  • The formula (X) provides a general definition of the compounds required as reaction components for carrying out the process (e) according to the invention. In this formula, Z preferably has those meanings which have already been mentioned in connection with the description of the compounds of the formula (I) according to the invention as being preferred, particularly preferred, very particularly preferred and especially preferred for this radical. E preferably represents chlorine, bromine, iodine, methanesulfonyl or p-toluenesulfonyl. E particularly preferably represents chlorine or bromine.
  • Compounds of the formula (X) are commercially available.
  • Suitable acid binders for carrying out the processes (a), (b), (c), (d), (e) and (f) according to the invention are in each case all inorganic and organic bases customary for such reactions. Preference is given to using alkaline earth metal or alkali metal hydroxides, such as sodium hydroxide, calcium hydroxide, potassium hydroxide, or else ammonium hydroxide, alkali metal carbonates, such as sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate, alkali metal or alkaline earth metal acetates, such as sodium acetate, potassium acetate, calcium acetate, and also tertiary amines, such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, pyridine, N-methylpiperidine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU). However, it is also possible to operate without added acid binder or to use an excess of the amine component so that it simultaneously acts as acid binder.
  • Suitable diluents for carrying out the processes (a), (b), (c), (d), (e) and (f) according to the invention are in each case all customary inert organic solvents. Preference is given to using optionally halogenated aliphatic, alicyclic or aromatic hydrocarbons, such as petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichlorethane or trichloroethane; ethers, such as diethyl ether, diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; nitriles, such as acetonitrile, propionitrile, n- or isobutyronitrile or benzonitrile; amides, such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric triamide; esters, such as methyl acetate or ethyl acetate, sulfoxides, such as dimethyl sulfoxide, or sulfones, such as sulfolane.
  • When carrying out the processes (a), (b), (c), (d), (e) and (f) according to the invention, the reaction temperatures can in each case be varied within a relatively wide range. In general, the processes are carried out at temperatures between 0° C. and 140° C., preferably between 10° C. and 120° C.
  • The process (a), (b), (c), (d), (e) and (f) according to the invention are generally in each case carried out under atmospheric pressure. However, in each case it is also possible to operate under elevated or reduced pressure.
  • When carrying out the process (a) according to the invention, in general 1 mol or else an excess of aniline derivative of the formula (III) and from 1 to 3 mol of acid binder are employed per mole of acid halide of the formula (II). However, it is also possible to employ the reaction components in other ratios. Work-up is carried out by customary methods. In general, water is added to the reaction mixture and the organic phase is separated off and, after drying, concentrated under reduced pressure. The residue that remains may, if required, be freed of any impurities that may still be present using customary methods, such as chromatography or recrystallization.
  • When carrying out the process (b) according to the invention, in general 1 mol or else an excess of boronic acid derivative of the formula (V) and from 1 to 5 mol of acid binder are employed per mole of carboxamide of the formula (IV). However, it is also possible to employ the reaction components in other ratios. Work-up is carried out by customary methods. In general, water is added to the reaction mixture and the precipitate is separated off and dried. The residue that remains may, if required, be freed of any impurities that may still be present using customary methods, such as chromatography or recrystallization.
  • When carrying out the process (c) according to the invention, in general 1 mol or else an excess of phenyloxime derivative of the formula (VII) and from 1 to 10 mol of acid binder and from 0.5 to 5 mol % of a catalyst are employed per mole of carboxamide boronic acid derivative of the formula (VI). However, it is also possible to employ the reaction components in other ratios. Work-up is carried out by customary methods. In general, water is added to the reaction mixture and the precipitate is separated off and dried. The residue that remains may, if required, be freed of any impurities that may still be present using customary methods, such as chromatography or recrystallization.
  • When carrying out the process (d) according to the invention, in general 1 mol or else an excess of hydroxylamine derivative of the formula (IX) and from 1 to 5 mol of acid binder are employed per mole of biphenylacyl derivative of the formula (VIII). However, it is also possible to employ the reaction components in other ratios. Work-up is carried out by customary methods. In general, water is added to the reaction mixture and the precipitate is separated off, washed with water and diisopropyl ether and then dried. The residue that remains may, if required, be freed of any impurities that may still be present using customary methods, such as chromatography or recrystallization.
  • When carrying out the process (e) according to the invention, in general 1 mol or else an excess of reagent of the formula (X) and from 1 to 5 mol of acid binder are employed per mole of hydroxyimino derivative of the formula (I-a). However, it is also possible to employ the reaction components in other ratios. Work-up is carried out by customary methods. In general, water is added to the reaction mixture and the precipitate is separated off and dried. The residue that remains may, if required, be freed of any impurities that may still be present using customary methods, such as chromatography or recrystallization.
  • When carrying out the process (f) according to the invention, in general 1 mol or else an excess of phenyloxime derivative of the formula (VII) and from 1 to 5 mol of acid binder and from 1 to 5 mol of a catalyst are employed per mole of carboxamide derivative of the formula (IV). However, it is also possible to employ the reaction components in other ratios. Work-up is carried out by customary methods. In general, water is added to the reaction mixture and the precipitate is separated off and dried. The residue that remains may, if required, be freed of any impurities that may still be present using customary methods, such as chromatography or recrystallization.
  • The active compounds are suitable for protecting plants and plant organs, increasing harvest yields, improving the quality of the harvested material and controlling animal pests, in particular insects, arachnids and nematodes, which are encountered in agriculture, in forests, in gardens and in leisure facilities, in the protection of stored products and of materials, and in the hygiene sector and they are tolerated well by plants, have favorable homeotherm toxicity and good environmental compatibility. They may preferably be employed as crop protection agents. They are active against normally sensitive and resistant species and against all or some stages of development. The abovementioned pests include:
  • From the order of the Isopoda, for example, Oniscus asellus, Armadillidium vulgare and Porcellio scaber.
  • From the order of the Diplopoda, for example, Blaniulus guttulatus.
  • From the order of the Chilopoda, for example, Geophilus carpophagus and Scutigera spp.
  • From the order of the Symphyla, for example, Scutigerella immaculata.
  • From the order of the Thysanura, for example, Lepisma saccharina.
  • From the order of the Collembola, for example, Onychiurus armatus.
  • From the order of the Orthoptera, for example, Acheta domesticus, Gryllotalpa spp., Locusta migratoria migratorioides, Melanoplus spp. and Schistocerca gregaria.
  • From the order of the Blattaria, for example, Blatta orientalis, Periplaneta americana, Leucophaea maderae and Blattella germanica.
  • From the order of the Dermaptera, for example, Forficula auricularia.
  • From the order of the Isoptera, for example, Reticulitermes spp.
  • From the order of the Phthiraptera, for example, Pediculus humanus corporis, Haematopinus spp., Linognathus spp., Trichodectes spp. and Damalinia spp.
  • From the order of the Thysanoptera, for example, Hercinothrips femoralis, Thrips tabaci, Thrips palmi and Franidiniella accidentalis.
  • From the order of the Heteroptera, for example, Eurygaster spp., Dysdercus intermedius, Piesma quadrata, Cimex lectularius, Rhodnius prolixus and Triatoma spp.
  • From the order of the Homoptera, for example, Aleurodes brassicae, Bemisia tabaci, Trialeurodes vaporariorum, Aphis gossypii, Brevicoryne brassicae, Cryptomyzus ribis, Aphis fabae, Aphis pomi, Eriosoma lanigerum, Hyalopterus arundinis, Phylloxera vastatrix, Pemphigus spp., Macrosiphum avenae, Myzus spp., Phorodon humuli, Rhopalosiphum padi, Empoasca spp., Euscelis bilobatus, Nephotettix cincticeps, Lecanium corni, Saissetia oleae, Laodelphax striatellus, Nilaparvata lugens, Aonidiella aurantii, Aspidiotus hederae, Pseudococcus spp. and Psylla spp.
  • From the order of the Lepidoptera, for example, Pectinophora gossypiella, Bupalus piniarius, Chematobia brumata, Lithocolletis blancardella, Hyponomeuta padella, Plutella xylostella, Malacosoma neustria, Euproctis chrysorrhoea, Lymantria spp., Bucculatrix thurberiella, Phyllocnistis citrella, Agrotis spp., Euxoa spp., Feltia spp., Earias insulana, Heliothis spp., Mamestra brassicae, Panolis flammea, Spodoptera spp., Trichoplusia ni, Carpocapsa pomonella, Pieris spp., Chilo spp., Pyrausta nubilalis, Ephestia kuehniella, Galleria mellonella, Tineola bisselliella, Tinea pellionella, Hofmannophila pseudospretella, Cacoecia podana, Capua reticulana, Choristoneura fumiferana, Clysia ambiguella, Homona magnanima, Tortrix viridana, Cnaphalocerus spp. and Oulema oryzae.
  • From the order of the Coleoptera, for example, Anobium punctatum, Rhizopertha dominica, Bruchidius obtectus, Acanthoscelides obtectus, Hylotrupes bajulus, Agelastica alni, Leptinotarsa decemlineata, Phaedon cochleariae, Diabrotica spp., Psylliodes chrysocephala, Epilachna varivestis, Atomaria spp., Oryzaephilus surinamensis, Anthonomus spp., Sitophilus spp., Otiorrhynchus sulcatus, Cosmopolites sordidus, Ceuthorrhynchus assimilis, Hypera postica, Dermestes spp., Trogoderma spp., Anthrenus spp., Attagenus spp., Lyctus spp., Meligethes aeneus, Ptinus spp., Niptus hololeucus, Gibbium psylloides, Tribolium spp., Tenebrio molitor, Agriotes spp., Conoderus spp., Melolontha melolontha, Amphimallon solstitialis, Costelytra zealandica and Lissorhoptrus oryzophilus.
  • From the order of the Hymenoptera, for example, Diprion spp., Hoplocampa spp., Lasius spp., Monomorium pharaonis and Vespa spp.
  • From the order of the Diptera, for example, Aedes spp., Anopheles spp., Culex spp., Drosophila melanogaster, Musca spp., Fannia spp., Calliphora erythrocephala, Lucilia spp., Chrysomyia spp., Cuterebra spp., Gastrophilus spp., Hyppobosca spp., Stomoxys spp., Oestrus spp., Hypoderma spp., Tabanus spp., Tannia spp., Bibio hortulanus, Oscinella frit, Phorbia spp., Pegomyia hyoscyami, Ceratitis capitata, Dacus oleae, Tipula paludosa, Hylemyia spp. and Liriomyza spp.
  • From the order of the Siphonaptera, for example, Xenopsylla cheopis and Ceratophyllus spp.
  • From the class of the Arachnida, for example, Scorpio maurus, Latrodectus mactans, Acarus siro, Argas spp., Ornithodoros spp., Dermanyssus gallinae, Eriophyes ribis, Phyllocoptruta oleivora, Boophilus spp., Rhipicephalus spp., Amblyomma spp., Hyalomma spp., Ixodes spp., Psoroptes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa, Panonychus spp., Tetranychus spp., Hemitarsonemus spp. and Brevipalpus spp.
  • The phytoparasitic nematodes include, for example, Pratylenchus spp., Radopholus similis, Ditylenchus dipsaci, Tylenchulus semipenetrans, Heterodera spp., Globodera spp., Meloidogyne spp., Aphelenchoides spp., Longidorus spp., Xiphinema spp., Trichodorus spp., Bursaphelenchus spp.
  • The compounds according to the invention have potent microbicidal activity and can be employed for controlling undesirable microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials.
  • Fungicides can be employed in crop protection for controlling Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.
  • Bactericides can be employed in crop protection for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.
  • Some pathogens causing fungal and bacterial diseases which come under the generic names listed above may be mentioned as examples, but not by way of limitation:
  • Xanthomonas species, such as, for example, Xanthomonas campestris pv. oryzae;
  • Pseudomonas species, such as, for example, Pseudomonas syringae pv. lachrymans;
  • Erwinia species, such as, for example, Erwinia amylovora;
  • Pythium species, such as, for example, Pythium ultimum;
  • Phytophthora species, such as, for example, Phytophthora infestans;
  • Pseudoperonospora species, such as, for example, Pseudoperonospora humuli or Pseudoperonospora cubensis;
  • Plasmopara species, such as, for example, Plasmopara viticola;
  • Bremia species, such as, for example, Bremia lactucae;
  • Peronospora species, such as, for example, Peronospora pisi or P. brassicae;
  • Erysiphe species, such as, for example, Erysiphe graminis;
  • Sphaerotheca species, such as, for example, Sphaerotheca fuliginea;
  • Podosphaera species, such as, for example, Podosphaera leucotricha;
  • Venturia species, such as, for example, Venturia inaequalis;
  • Pyrenophora species, such as, for example, Pyrenophora teres or P. graminea (conidia form: Drechslera, syn: Helminthosporium);
  • Cochliobolus species, such as, for example, Cochliobolus sativus (conidia form: Drechslera, syn: Helminthosporium);
  • Uromyces species, such as, for example, Uromyces appendiculatus;
  • Puccinia species, such as, for example, Puccinia recondita;
  • Sclerotinia species, such as, for example, Sclerotinia sclerotiorum;
  • Tilletia species, such as, for example, Tilletia caries;
  • Ustilago species, such as, for example, Ustilago nuda or Ustilago avenae;
  • Pellicularia species, such as, for example, Pellicularia sasakii;
  • Pyricularia species, such as, for example, Pyricularia oryzae;
  • Fusarium species, such as, for example, Fusarium culmorum;
  • Botrytis species, such as, for example, Botrytis cinerea;
  • Septoria species, such as, for example, Septoria nodorum;
  • Leptosphaeria species, such as, for example, Leptosphaeria nodorum;
  • Cercospora species, such as, for example, Cercospora canescens;
  • Alternaria species, such as, for example, Alternaria brassicae; and
  • Pseudocercosporella species, such as, for example, Pseudocercosporella herpotrichoides.
  • The active compounds according to the invention also have very good fortifying action in plants. Accordingly, they can be used for mobilizing the defences of the plant against attack by undesirable microorganisms.
  • In the present context, plant-fortifying (resistance-inducing) substances are to be understood as meaning those substances which are capable of stimulating the defence system of plants such that, when the treated plants are subsequently inoculated with undesirable microorganisms, they show substantial resistance to these microorganisms.
  • In the present case, undesirable microorganisms are to be understood as meaning phytopathogenic fungi, bacteria and viruses. Accordingly, the substances according to the invention can be used to protect plants for a certain period after the treatment against attack by the pathogens mentioned. The period for which protection is provided generally extends over 1 to 10 days, preferably 1 to 7 days, after the treatment of the plants with the active compounds.
  • The fact that the active compounds are well tolerated by plants at the concentrations required for controlling plant diseases permits the treatment of above-ground parts of plants, of propagation stock and seeds, and of the soil.
  • The active compounds according to the invention can be used with particularly good results for controlling diseases in viticulture and in the cultivation of fruit and vegetables, such as, for example, against Venturia, Botrytis, Sclerotina, Rhizoctonia, Uncinula, Sphaerotheca, Podosphaera, Alternaria and Colletotrichum species. Rice diseases, such as Pyricularia and Pellicularia species, are likewise controlled with good results.
  • The active compounds according to the invention are also suitable for increasing the yield of crops. In addition, they show reduced toxicity and are well tolerated by plants.
  • At certain concentrations and application rates, the active compounds according to the invention can also be used as herbicides, for influencing plant growth and for controlling animal pests. If appropriate, they can also be used as intermediates and precursors for the synthesis of further active compounds.
  • All plants and plant parts can be treated in accordance with the invention. Plants are to be understood as meaning in the present context all plants and plant populations such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants which can be obtained by conventional plant breeding and optimization methods or by biotechnological and recombinant methods or by combinations of these methods, including the transgenic plants and inclusive of the plant cultivars protectable or not protectable by plant breeders' rights. Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, examples which may be mentioned being leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. The plant parts also include harvested material, and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds.
  • Treatment according to the invention of the plants and plant parts with the active compounds is carried out directly or by allowing the compounds to act on the surroundings, environment or storage space by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on, injection, and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats.
  • In the protection of materials, the substances according to the invention can be employed for protecting industrial materials against infection with, and destruction by, undesired microorganisms.
  • Industrial materials in the present context are understood as meaning non-living materials which have been prepared for use in industry. For example, industrial materials which are intended to be protected by active compounds according to the invention from microbial change or destruction can be adhesives, sizes, paper and board, textiles, leather, wood, paints and plastic articles, cooling lubricants and other materials which can be infected with, or destroyed by, microorganisms. Parts of production plants, for example cooling-water circuits, which may be impaired by the proliferation of microorganisms may also be mentioned within the scope of the materials to be protected. Industrial materials which may be mentioned within the scope of the present invention are preferably adhesives, sizes, paper and board, leather, wood, paints, cooling lubricants and heat-transfer liquids, particularly preferably wood.
  • Microorganisms capable of degrading or changing the industrial materials which may be mentioned are, for example, bacteria, fungi, yeasts, algae and slime organisms. The active compounds according to the invention preferably act against fungi, in particular molds, wood-discoloring and wood-destroying fungi (Basidiomycetes), and against slime organisms and algae.
  • Microorganisms of the following genera may be mentioned as examples:
  • Alternaria, such as Alternaria tenuis,
  • Aspergillus, such as Aspergillus niger,
  • Chaetomium, such as Chaetomium globosum,
  • Coniophora, such as Coniophora puetana,
  • Lentinus, such as Lentinus tigrinus,
  • Penicillium, such as Penicillium glaucum,
  • Polyporus, such as Polyporus versicolor,
  • Aureobasidium, such as Aureobasidium pullulans,
  • Sclerophoma, such as Sclerophoma pityophila,
  • Trichoderma, such as Trichoderma viride,
  • Escherichia, such as Escherichia coli,
  • Pseudomonas, such as Pseudomonas aeruginosa, and
  • Staphylococcus, such as Staphylococcus aureus.
  • Depending on their particular physical and/or chemical properties, the active compounds can be converted to the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols and microencapsulations in polymeric substances and in coating compositions for seeds, and ULV cool and warm fogging formulations.
  • These formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is, liquid solvents, liquefied gases under pressure, and/or solid carriers, optionally with the use of surfactants, that is emulsifiers and/or dispersants, and/or foam formers. If the extender used is water, it is also possible to employ, for example, organic solvents as auxiliary solvents. Essentially, suitable liquid solvents are: aromatics such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons such as cyclohexane or paraffins, for example petroleum fractions, alcohols such as butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide or dimethyl sulfoxide, or else water. Liquefied gaseous extenders or carriers are to be understood as meaning liquids which are gaseous at standard temperature and under atmospheric pressure, for example aerosol propellants such as halogenated hydrocarbons, or else butane, propane, nitrogen and carbon dioxide. Suitable solid carriers are: for example ground natural minerals such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals such as finely divided silica, alumina and silicates. Suitable solid carriers for granules are: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, or else synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks. Suitable emulsifiers and/or foam formers are: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates, or else protein hydrolysates. Suitable dispersants are: for example lignosulphite waste liquors and methylcellulose.
  • Tackifiers such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, or else natural phospholipids such as cephalins and lecithins and synthetic phospholipids can be used in the formulations. Other possible additives are mineral and vegetable oils.
  • It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • The formulations generally comprise between 0.1 and 95 percent by weight of active compound, preferably between 0.5 and 90%.
  • The active compounds according to the invention can be used as such or in their formulations, also in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, to broaden, for example, the activity spectrum or to prevent development of resistance. In many cases, synergistic effects are obtained, i.e. the activity of the mixture is greater than the activity of the individual components.
  • Examples of suitable mixing components are the following compounds:
    • Fungicides:
  • 2-phenylphenol; 8-hydroxyquinoline sulfate; acibenzolar-S-methyl; aldimorph; amidoflumet; ampropylfos; ampropylfos-potassium; andoprim; anilazine; azaconazole; azoxystrobin; benalaxyl; benodanil; benomyl; benthiavalicarb-isopropyl; benzamacril; benzamacril-isobutyl; bilanafos; binapacryl; biphenyl; bitertanol; blasticidin-S; bromuconazole; bupirimate; buthiobate; butylamine; calcium polysulfide; capsimycin; captafol; captan; carbendazim; carboxin; carpropamid; carvone; chinomethionat; chlobenthiazone; chlorfenazole; chloroneb; chlorothalonil; chlozolinate; clozylacon; cyazofamid; cyflufenamid; cymoxanil; cyproconazole; cyprodinil; cyprofuram; Dagger G; debacarb; dichlofluanid; dichlone; dichlorophen; diclocymet; diclomezine; dicloran; diethofencarb; difenoconazole; diflumetorim; dimethirimol; dimethomorph; dimoxystrobin; diniconazole; diniconazole-M; dinocap; diphenylamine; dipyrithione; ditalimfos; dithianon; dodine; drazoxolon; edifenphos; epoxiconazole; ethaboxam; ethirimol; etridiazole; famoxadone; fenamidone; fenapanil; fenarimol; fenbuconazole; fenfuram; fenhexamid; fenitropan; fenoxanil; fenpiclonil; fenpropidin; fenpropimorph; ferbam; fluazinam; flubenzimine; fludioxonil; flumetover; flumorph; fluoromide; fluoxastrobin; fluquinconazole; flurprimidol; flusilazole; flusulfamide; flutolanil; flutriafol; folpet; fosetyl-Al; fosetyl-sodium; fuberidazole; furalaxyl; furametpyr; furcarbanil; furmecyclox; guazatine; hexachlorobenzene; hexaconazole; hymexazole; imazalil; imibenconazole; iminoctadine triacetate; iminoctadine tris(albesil); iodocarb; ipconazole; iprobenfos; iprodione; iprovalicarb; irumamycin; isoprothiolane; isovaledione; kasugamycin; kresoxim-methyl; mancozeb; maneb; meferimzone; mepanipyrim; mepronil; metalaxyl; metalaxyl-M; metconazole; methasulfocarb; methfuroxam; metiram; metominostrobin; metsulfovax; mildiomycin; myclobutanil; myclozolin; natamycin; nicobifen; nitrothal-isopropyl; noviflumuron; nuarimol; ofurace; orysastrobin; oxadixyl; oxolinic acid; oxpoconazole; oxycarboxin; oxyfenthiin; paclobutrazole; pefurazoate; penconazole; pencycuron; phosdiphen; phthalide; picoxystrobin; piperalin; polyoxins; polyoxorim; probenazole; prochloraz; procymidone; propamocarb; propanosine-sodium; propiconazole; propineb; proquinazid; prothioconazole; pyraclostrobin; pyrazophos; pyrifenox; pyrimethanil; pyroquilon; pyroxyfur; pyrrolenitrine; quinconazole; quinoxyfen; quintozene; simeconazole; spiroxamine; sulfur; tebuconazole; tecloftalam; tecnazene; tetcyclacis; tetraconazole; thiabendazole; thicyofen; thifluzamide; thiophanate-methyl; thiram; tioxymid; tolclofos-methyl; tolylfluanid; triadimefon; triadimenol; triazbutil; triazoxide; tricyclamide; tricyclazole; tridemorph; trifloxystrobin; triflumizole; triforine; triticonazole; uniconazole; validamycin A; vinclozolin; zineb; ziram; zoxamide; (2S)-N-[2-[4-[[3-(4-chlorophenyl)-2-propynyl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)amino]butanamide; 1-(1-naphthalenyl)-1H-pyrrole-2,5-dione; 2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine; 2-amino-4-methyl-N-phenyl-5-thiazolecarboxamide; 2-chloro-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-3-pyridinecarboxamide; 3,4,5-trichloro-2,6-pyridinedicarbonitrile; actinovate; cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)cycloheptanol; methyl 1-(2,3-dihydro-2,2-dimethyl-1H-inden-1-yl)-1H-imidazole-5-carboxylate; monopotassium carbonate; N-(6-methoxy-3-pyridinyl)cyclopropanecarboxamide; N-butyl-8-(1,1-dimethylethyl)-1-oxaspiro[4.5]decane-3-amine; sodium tetrathiocarbonate; and copper salts and preparations, such as Bordeaux mixture; copper hydroxide; copper naphthenate; copper oxychloride; copper sulfate; cufraneb; cuprous oxide; mancopper; oxine-copper.
    • Bactericides:
  • bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulfate and other copper preparations.
    • Insecticides/Acaricides/Nematicides:
  • abamectin, ABG-9008, acephate, acequinocyl, acetamiprid, acetoprole, acrinathrin, AKD-1022, AKD-3059, AKD-3088, alanycarb, aldicarb, aldoxycarb, allethrin, allethrin 1R-isomers, alpha-cypermethrin (alphamethrin), amidoflumet, aminocarb, amitraz, avermectin, AZ-60541, azadirachtin, azamethiphos, azinphos-methyl, azinphos-ethyl, azocyclotin, Bacillus popilliae, Bacillus sphaericus, Bacillus subtilis, Bacillus thuringiensis, Bacillus thuringiensis strain EG-2348, Bacillus thuringiensis strain GC-91, Bacillus thuringiensis strain NCTC-11821, baculoviruses, Beauveria bassiana, Beauveria tenella, bendiocarb, benfuracarb, bensultap, benzoximate, beta-cyfluthrin, beta-cypermethrin, bifenazate, bifenthrin, binapacryl, bioallethrin, bioallethrin-S-cyclopentyl-isomer, bioethanomethrin, biopermethrin, bioresmethrin, bistrifluoron, BPMC, brofenprox, bromophos-ethyl, bromopropylate, bromfenvinfos (-methyl), BTG-504, BTG-505, bufencarb, buprofezin, butathiofos, butocarboxim, butoxycarboxim, butylpyridaben, cadusafos, camphechlor, carbaryl, carbofuran, carbophenothion, carbosulfan, cartap, CGA-50439, chinomethionat, chlordane, chlordimeform, chloethocarb, chlorethoxyfos, chlorfenapyr, chlorfenvinphos, chlorfluazuron, chlormephos, chlorobenzilate, chloropicrin, chlorproxyfen, chlorpyrifos-methyl, chlorpyrifos (-ethyl), chlovaporthrin, chromafenozide, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocythrin, cloethocarb, clofentezine, clothianidin, clothiazoben, codlemone, coumaphos, cyanofenphos, cyanophos, cycloprene, cycloprothrin, Cydia pomonella, cyfluthrin, cyhalothrin, cyhexatin, cypermethrin, cyphenothrin (1R-trans-isomer), cyromazine, DDT, deltamethrin, demeton-S-methyl, demeton-S-methylsulfone, diafenthiuron, dialifos, diazinon, dichlofenthion, dichlorvos, dicofol, dicrotophos, dicyclanil, diflubenzuron, dimethoate, dimethylvinphos, dinobuton, dinocap, dinotefuran, diofenolan, disulfoton, docusat-sodium, dofenapyn, DOWCO-439, eflusilanate, emamectin, emamectin-benzoate, empenthrin (1R-isomer), endosulfan, Entomopthora spp., EPN, esfenvalerate, ethiofencarb, ethiprole, ethion, ethoprophos, etofenprox, etoxazole, etrimfos, famphur, fenamiphos, fenazaquin, fenbutatin oxide, fenfluthrin, fenitrothion, fenobucarb, fenothiocarb, fenoxacrim, fenoxycarb, fenpropathrin, fenpyrad, fenpyrithrin, fenpyroximate, fensulfothion, fenthion, fentrifanil, fenvalerate, fipronil, flonicamid, fluacrypyrim, fluazuron, flubenzimine, flubrocythrinate, flucycloxuron, flucythrinate, flufenerim, flufenoxuron, flufenprox, flumethrin, flupyrazofos, flutenzin (flufenzine), fluvalinate, fonofos, formetanate, formothion, fosmethilan, fosthiazate, fubfenprox (fluproxyfen), furathiocarb, gamma-HCH, gossyplure, grandlure, granulosis viruses, halfenprox, halofenozide, HCH, HCN-801, heptenophos, hexaflumuron, hexythiazox, hydramethylnone, hydroprene, IKA-2002, imidacloprid, imiprothrin, indoxacarb, iodofenphos, iprobenfos, isazofos, isofenphos, isoprocarb, isoxathion, ivermectin, japonilure, kadethrin, nuclear polyhedrosis viruses, kinoprene, lambda-cyhalothrin, lindane, lufenuron, malathion, mecarbam, mesulfenfos, metaldehyde, metam-sodium, methacrifos, methamidophos, Metharhizium anisopliae, Metharhizium flavoviride, methidathion, methiocarb, methomyl, methoprene, methoxychlor, methoxyfenozide, metolcarb, metoxadiazone, mevinphos, milbemectin, milbemycin, MKI-245, MON-45700, monocrotophos, moxidectin, MTI-800, naled, NC-104, NC-170, NC-184, NC-194, NC-196, niclosamide, nicotine, nitenpyram, nithiazine, NNI-0001, NNI-0101, NNI-0250, NNI-9768, novaluron, noviflumuron, OK-5101, OK-5201, OK-9601, OK-9602, OK-9701, OK-9802, omethoate, oxamyl, oxydemeton-methyl, Paecilomyces fumosoroseus, parathion-methyl, parathion (-ethyl), permethrin (cis-, trans-), petroleum, PH-6045, phenothrin (1R-trans isomer), phenthoate, phorate, phosalone, phosmet, phosphamidon, phosphocarb, phoxim, piperonyl butoxide, pirimicarb, pirimiphos-methyl, pirimiphos-ethyl, prallethrin, profenofos, promecarb, propaphos, propargite, propetamphos, propoxur, prothiofos, prothoate, protrifenbute, pymetrozine, pyraclofos, pyresmethrin, pyrethrum, pyridaben, pyridalyl, pyridaphenthion, pyridathion, pyrimidifen, pyriproxyfen, quinalphos, resmethrin, RH-5849, ribavirin, RU-12457, RU-15525, S-421, S-1833, salithion, sebufos, SI-0009, silafluofen, spinosad, spirodiclofen, spiromesifen, sulfluramid, sulfotep, sulprofos, SZI-121, tau-fluvalinate, tebufenozide, tebufenpyrad, tebupirimfos, teflubenzuron, tefluthrin, temephos, temivinphos, terbam, terbufos, tetrachlorvinphos, tetradifon, tetramethrin, tetramethrin (1R-isomer), tetrasul, theta-cypermethrin, thiacloprid, thiamethoxam, thiapronil, thiatriphos, thiocyclam hydrogen oxalate, thiodicarb, thiofanox, thiometon, thiosultap-sodium, thuringiensin, tolfenpyrad, tralocythrin, tralomethrin, transfluthrin, triarathene, triazamate, triazophos, triazuron, trichlophenidine, trichlorfon, triflumuron, trimethacarb, vamidothion, vaniliprole, verbutin, Verticillium lecanii, WL-108477, WL-40027, yl-5201, yl-5301, yl-5302, XMC, xylylcarb, ZA-3274, zeta-cypermethrin, zolaprofos, ZXI-8901, the compound 3-methylphenyl propylcarbamate (tsumacide Z), the compound 3-(5-chloro-3-pyridinyl)-8-(2,2,2-trifluoroethyl)-8-azabicyclo[3.2.1]octane-3-carbonitrile (CAS-Reg. No. 185982-80-3) and the corresponding 3-endo-isomer (CAS-Reg. No. 185984-60-5) (cf. WO-96/37494, WO-98/25923), and also preparations which comprise insecticidally active plant extracts, nematodes, fungi or viruses.
  • A mixture with other known active compounds, such as herbicides, or with fertilizers and growth regulators, safeners or semicochemicals, is also possible.
  • In addition, the compounds of the formula (I) according to the invention also have very good antimycotic activity. They have a very broad antimycotic activity spectrum in particular against dermatophytes and yeasts, moulds and diphasic fungi (for example against Candida species, such as Candida albicans, Candida glabrata), and Epidermophyton floccosum, Aspergillus species, such as Aspergillus niger and Aspergillus fumigatus, Trichophyton species, such as Trichophyton mentagrophytes, Microsporon species such as Microsporon canis and audouinii. The list of these fungi by no means limits the mycotic spectrum covered, but is only for illustration.
  • The active compounds can be used as such, in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, suspensions, wettable powders, pastes, soluble powders, dusts and granules. Application is carried out in a customary manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming, spreading, etc. It is furthermore possible to apply the active compounds by the ultra-low-volume method, or to inject the active compound preparation or the active compound itself into the soil. It is also possible to treat the seeds of the plants.
  • When using the active compounds according to the invention as fungicides, the application rates can be varied within a relatively wide range, depending on the kind of application. For the treatment of parts of plants, the active compound application rates are generally between 0.1 and 10 000 g/ha, preferably between 10 and 1000 g/ha. For seed dressing, the active compound application rates are generally between 0.001 and 50 g per kilogram of seed, preferably between 0.01 and 10 g per kilogram of seed. For the treatment of the soil, the active compound application rates are generally between 0.1 and 10 000 g/ha, preferably between 1 and 5000 g/ha.
  • The compositions used for protecting industrial materials generally comprise the active compounds in an amount of from 1 to 95%, preferably from 10 to 75%.
  • The application concentrations of the active compounds according to the invention depend on the nature and the occurrence of the microorganisms to be controlled and on the composition of the material to be protected. The optimum amount for application can be determined by test series. In general, the application concentrations are in the range from 0.001 to 5% by weight, preferably from 0.05 to 1.0% by weight, based on the material to be protected.
  • The activity and the activity spectrum of the active compounds to be used according to the invention in the protection of materials, or of the compositions, concentrates or, quite generally, formulations preparable therefrom, can be increased, if appropriate, by addition of further antimicrobially active compounds, fungicides, bactericides, herbicides, insectizides or other active compounds for widening the activity spectrum or obtaining special effects such as, for example, additional protection against insects. These mixtures may have a wider activity spectrum than the compounds according to the invention.
  • When used as insecticides in their commercially available formulations and in the use forms prepared with these formulations, the active compounds according to the invention can furthermore be present in the form of a mixture with synergists. Synergists are compounds by which the activity of the active compounds is increased without it being necessary for the synergist added to be active itself.
  • When used as insecticides in their commercially available formulations and in the use forms prepared with these formulations, the active compounds according to the invention can furthermore be present in the form of a mixture with inhibitors which reduce the degradation of the active compound after application in the habitat of the plant, on the surface of parts of plants or in plant tissues.
  • The active compound content of the use forms prepared from the commercially available formulations can vary within broad ranges. The active compound concentration of the use forms can be from 0.0000001 up to 95% by weight of active compound, preferably between 0.0001 and 1% by weight.
  • They are applied in a customary manner adapted to suit the use forms.
  • When used against hygiene pests and pests of stored products, the active compound is distinguished by excellent residual action on wood and clay as well as good stability to alkali on limed substrates.
  • As already mentioned above, it is possible to treat all plants or their parts in accordance with the invention. In a preferred embodiment, wild plant species or plant varieties and plant cultivars which have been obtained by traditional biological breeding methods, such as hybridization or protoplast fusion, and the parts of these varieties and cultivars are treated. In a further preferred embodiment, transgenic plants and plant cultivars which have been obtained by recombinant methods, if appropriate in combination with conventional methods (genetically modified organisms), and their parts are treated. The term “parts” or “parts of plants” or “plant parts” has been explained above.
  • Plants which are treated particularly preferably in accordance with the invention are those of the plant cultivars which are in each case commercially available or in use. Plant cultivars are understood as meaning plants with new traits which have been bred either by conventional breeding, by mutagenesis or by recombinant DNA techniques. They may take the form of cultivars, biotypes and genotypes.
  • Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, vegetation period, nutrition), the treatment according to the invention may also result in superadditive (“synergistic”) effects. Thus, for example, reduced application rates and/or a widened activity spectrum and/or an increase in the activity of the substances and compositions which can be used in accordance with the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to salinity in the water or soil, increased flowering performance, facilitated harvesting, accelerated maturation, higher yields, higher quality and/or better nutritional value of the harvested products, better storage characteristics and/or processability of the harvested products are possible which exceed the effects which were actually to be expected.
  • The preferred transgenic plants or plant cultivars (those obtained by recombinant methods) to be treated in accordance with the invention include all those plants which, owing to the process of recombinant modification, were given genetic material which confers particular, advantageous, valuable traits to these plants. Examples of such properties are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to salinity in the water or soil, increased flowering performance, facilitated harvesting, accelerated maturation, higher yields, higher quality and/or higher nutritional value of the harvested products, better storage characteristics and/or better processability of the harvested products. Further examples of such traits, examples which must be mentioned especially, are better defence of the plants against animal and microbial pests, such as against insects, mites, phytopathogenic fungi, bacteria and/or viruses and an increased tolerance of the plants to certain herbicidal active compounds. Examples of transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice), maize, soybeans, potato, cotton, tobacco, oilseed rape and fruit plants (with the fruits apples, pears, citrus fruits and grapes), with particular emphasis on maize, soybeans, potatoes, cotton, tobacco, and oilseed rape. Traits which are especially emphasized are the increased defence of the plants against insects, arachnids, nematodes, and slugs and snails owing to toxins being formed in the plants, in particular toxins which are generated in the plants by the genetic material of Bacillus thuringiensis (for example by the genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CryIF and their combinations; hereinbelow “Bt plants”). Other traits which are particularly emphasized are the increased defence of plants against fungi, bacteria and viruses by the systemic acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins. Other traits which are especially emphasized are the increased tolerance of the plants to certain herbicidal active compounds, for example imidazolinones, sulfonylureas, glyphosate or phosphinotricin (for example “PAT” gene). The genes which confer the desired traits in each case may also be present in the transgenic plants in combination with one another. Examples of “Bt plants” which may be mentioned are maize cultivars, cotton cultivars, soybean cultivars and potato cultivars which are commercially available under the trade names YIELD GARD® (for example maize, cotton, soybean), KnockOut® (for example maize), StarLink® (for example maize), Bollgard® (cotton), Nucotn® (cotton) and NewLeaf® (potato). Examples of herbicide-tolerant plants which may be mentioned are maize cultivars, cotton cultivars and soybean cultivars which are commercially available under the trade names Roundup Ready® (tolerance to glyphosate, for example maize, cotton, soybean), Liberty Link® (tolerance to phosphinotricin, for example oilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance to sulfonylureas, for example maize) Herbicide-resistant plants (plants bred in a conventional manner for herbicide tolerance) which may be mentioned include also the varieties commercially available under the name Clearfield® (for example maize). Naturally, these statements also apply to plant cultivars having these genetic traits or genetic traits still to be developed, which plant cultivars will be developed and/or marketed in the future.
  • The plants listed can be treated particularly advantageously according to the invention with the compounds of the general formula (I) or the active compound mixtures according to the invention. The preferred ranges stated above for the active compounds and mixtures also apply to the treatment of these plants. Particular emphasis may be given to the treatment of plants with the compounds or mixtures specifically mentioned in the present text.
  • The preparation and the use of the active compounds according to the invention is illustrated by the examples below.
    • PREPARATION EXAMPLES Example 1
  • Figure US20100216849A1-20100826-C00108
    • Process (a)
  • 0.300 g (1.126 mmol) of 1-(2′-aminobiphenyl-4-yl)ethanone O-allyl oxime and 0.114 g (1.126 mmol) of triethylamine are initially charged in 20 ml of toluene. At room temperature, 0.199 g (1.126 mmol) of 5-fluoro-1,3-dimethyl-1H-pyrazole-4-carbonyl chloride is added to the reaction mixture, and the mixture is stirred at 50° C. for 2 h. For work-up, the reaction mixture is cooled to room temperature, washed twice with in each case 100 ml of water, dried over sodium sulfate and concentrated under reduced pressure. The residue is recrystallized from n-hexane.
  • This gives 0.44 g (94.4% of theory) of N-(4′-{1-(allyloxyimino)-ethyl}-biphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide (compound 17, Table 1) of melting point 118° C.
    • Example 2
  • Figure US20100216849A1-20100826-C00109
    • Process (a)
  • 0.300 g (1.000 mmol) of 2′-aminobiphenyl-4-carbaldehyde O-allyl oxime (III-1) and 0.120 g (1.000 mmol) of triethylamine are initially charged in 15 ml of toluene. At room temperature, 0.251 g (1.000 mmol) of 4-difluoromethyl-2-methylthiazole-5-carbonyl chloride, dissolved in 5 ml of toluene, is added to the reaction mixture, and the mixture is heated at 50° C. and stirred for 3 h. For work-up, the reaction mixture is cooled to room temperature and washed twice with in each case 80 ml of water, and the organic phase is dried over magnesium sulfate and then concentrated under reduced pressure. The residue is purified by silica gel column chromatography (hexane/methyl tert-butyl ether 3:1).
  • This gives 0.30 g (49.6% of theory) of N-[4′-(allyloxyimino-methyl)-biphenyl-2-yl]-4-difluoromethyl-2-methylthiazole-5-carboxamide (compound 9, Table 1).
  • 1H-NMR (DMSO-D6): δ=2.71 ppm (s, 3H)
    • Example 3
  • Figure US20100216849A1-20100826-C00110
    • Process (b)
  • At room temperature, 1.00 g (2.75 mmol) of N-(2-iodophenyl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, 0.61 g (2.78 mmol) of 4-[1-(allyloxyimino)ethyl]phenylboronic acid and 0.20 g of tetrakis(triphenylphosphine)palladium(0) are initially charged in 15 ml of dimethoxyethane. At room temperature, a solution of 1.18 g (11.14 mmol) of sodium carbonate in 15 ml of water is added with stirring. The mixture is heated at reflux temperature and stirred for 15 h. For work-up, the mixture is cooled to room temperature and extracted twice with in each case 50 ml of diethyl ether. The organic phases are washed with water, dried over sodium sulfate and concentrated under reduced pressure. The residue is purified by silica gel column chromatography (hexane/methyl tert-butyl ether 3:1).
  • This gives 0.13 g (10.5% of theory) of N-(4′-{1-(allyloxyimino)ethyl}biphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide (compound 17, Table 1) of log P (pH 2.3)=3.80.
    • Example 4
  • Figure US20100216849A1-20100826-C00111
    • Process (d)
  • 0.79 g (2.24 mmol) of N-(4′-acetylbiphenyl-2-yl)-2-chloronicotinamide (VIII-1), 0.40 g (2.24 mmol) of O-(3,3-dichloroallyl)hydroxylamine hydrochloride and 0.22 g of sodium acetate are initially charged in a mixture of 5 ml of methanol and 2 ml of water and stirred at room temperature for 15 h. For work-up, the mixture is stirred into 30 ml of water and then extracted with 30 ml of dichloromethane. The organic phase is washed with 15 ml of water, and the phases are separated. The organic phase is dried over sodium sulfate and then concentrated under reduced pressure. The residue is triturated in a little hot hexane and cooled, and the residue is filtered off with suction.
  • This gives 0.68 g (63.9% of theory) of 2-chloro-N-{4′-[1-(3,3-dichloroallyloxyimino)ethyl]-biphenyl-2-yl}nicotinamide (compound 63, Table 1) of log P (pH 2.3)=4.43.
    • Example 5
  • Figure US20100216849A1-20100826-C00112
    • Process (e)
  • At room temperature, 1.00 g (2.87 mmol) of N-{4′-[1-(hydroxyimino)ethyl]biphenyl-2-yl}-1,3-dimethyl-1H-pyrazole-4-carboxamide and 0.60 g of potassium carbonate (4.31 mmol) are initially charged in 50 ml of acetonitrile, and 0.417 g of 1,1,3-trichloropropene (2.870 mmol), dissolved in 5 ml of acetonitrile, are then added. The mixture is heated at reflux temperature and stirred for 15 h. For work-up, the mixture is cooled and filtered off with suction through a Nutsche filter, and the mother liquor is concentrated under reduced pressure. The residue is chromatographed on silica gel (hexane/acetone 9:1).
  • This gives 0.66 g (47.1% of theory) of N-(4′-{1-[3,3-dichloroallyloxyimino]ethyl}biphenyl-2-yl)-1,3-dimethyl-1H-pyrazole-4-carboxamide (compound 54, Table 1) as a solid of log P (pH 2.3)=3.97.
  • The biphenylcarboxamides of the formula (I-1) listed in the table below are likewise prepared according to Examples 1 to 5 and according to the general process descriptions and methods.
  • TABLE 1
    (I-1)
    Figure US20100216849A1-20100826-C00113
    No. A R Z logP (pH 2.3) m.p. (° C.)
    1
    Figure US20100216849A1-20100826-C00114
         		H
    Figure US20100216849A1-20100826-C00115
         		3.77
    2
    Figure US20100216849A1-20100826-C00116
         		H
    Figure US20100216849A1-20100826-C00117
         		4.16
    3
    Figure US20100216849A1-20100826-C00118
         		H
    Figure US20100216849A1-20100826-C00119
         		3.57
    4
    Figure US20100216849A1-20100826-C00120
         		H
    Figure US20100216849A1-20100826-C00121
         		3.77
    5
    Figure US20100216849A1-20100826-C00122
         		H
    Figure US20100216849A1-20100826-C00123
         		3.91 107-109
    6
    Figure US20100216849A1-20100826-C00124
         		H
    Figure US20100216849A1-20100826-C00125
         		3.47 88-90
    7
    Figure US20100216849A1-20100826-C00126
         		H
    Figure US20100216849A1-20100826-C00127
         		3.53
    8
    Figure US20100216849A1-20100826-C00128
         		H
    Figure US20100216849A1-20100826-C00129
         		3.87
    9
    Figure US20100216849A1-20100826-C00130
         		H
    Figure US20100216849A1-20100826-C00131
         		3.65
    10
    Figure US20100216849A1-20100826-C00132
         		H
    Figure US20100216849A1-20100826-C00133
         		3.32
    11
    Figure US20100216849A1-20100826-C00134
         		H
    Figure US20100216849A1-20100826-C00135
         		3.53 126
    12
    Figure US20100216849A1-20100826-C00136
         		H
    Figure US20100216849A1-20100826-C00137
         		3.30 88-90
    13
    Figure US20100216849A1-20100826-C00138
         		H
    Figure US20100216849A1-20100826-C00139
         		3.04
    14
    Figure US20100216849A1-20100826-C00140
         		CH3
    Figure US20100216849A1-20100826-C00141
         		3.61 78-80
    15
    Figure US20100216849A1-20100826-C00142
         		CH3
    Figure US20100216849A1-20100826-C00143
         		3.92 104-106
    16
    Figure US20100216849A1-20100826-C00144
         		CH3
    Figure US20100216849A1-20100826-C00145
         		3.81 155
    17
    Figure US20100216849A1-20100826-C00146
         		CH3
    Figure US20100216849A1-20100826-C00147
         		3.80 118
    18
    Figure US20100216849A1-20100826-C00148
         		CH3
    Figure US20100216849A1-20100826-C00149
         		3.57 135-137
    19
    Figure US20100216849A1-20100826-C00150
         		CH3
    Figure US20100216849A1-20100826-C00151
         		4.19 126-128
    20
    Figure US20100216849A1-20100826-C00152
         		CH3
    Figure US20100216849A1-20100826-C00153
         		4.54  76
    21
    Figure US20100216849A1-20100826-C00154
         		CH3
    Figure US20100216849A1-20100826-C00155
         		4.31 118-120
    22
    Figure US20100216849A1-20100826-C00156
         		CH3
    Figure US20100216849A1-20100826-C00157
         		4.69 78-79
    23
    Figure US20100216849A1-20100826-C00158
         		CH3
    Figure US20100216849A1-20100826-C00159
         		3.86 96-97
    24
    Figure US20100216849A1-20100826-C00160
         		CH3
    Figure US20100216849A1-20100826-C00161
         		4.45 122-124
    25
    Figure US20100216849A1-20100826-C00162
         		CH3
    Figure US20100216849A1-20100826-C00163
         		4.05 149-150
    26
    Figure US20100216849A1-20100826-C00164
         		CH3
    Figure US20100216849A1-20100826-C00165
         		4.09 141-142
    27
    Figure US20100216849A1-20100826-C00166
         		CH3
    Figure US20100216849A1-20100826-C00167
         		4.56 115-116
    28
    Figure US20100216849A1-20100826-C00168
         		CH3
    Figure US20100216849A1-20100826-C00169
         		4.43 116-117
    29
    Figure US20100216849A1-20100826-C00170
         		CH3
    Figure US20100216849A1-20100826-C00171
         		3.42 142-144
    30
    Figure US20100216849A1-20100826-C00172
         		CH3
    Figure US20100216849A1-20100826-C00173
         		3.82 154-155
    31
    Figure US20100216849A1-20100826-C00174
         		CH3
    Figure US20100216849A1-20100826-C00175
         		4.06 152
    32
    Figure US20100216849A1-20100826-C00176
         		CH3
    Figure US20100216849A1-20100826-C00177
         		4.87 137-138
    33
    Figure US20100216849A1-20100826-C00178
         		CH3
    Figure US20100216849A1-20100826-C00179
         		3.82 170-171
    34
    Figure US20100216849A1-20100826-C00180
         		CH3
    Figure US20100216849A1-20100826-C00181
         		4.19 132-133
    35
    Figure US20100216849A1-20100826-C00182
         		CH3
    Figure US20100216849A1-20100826-C00183
         		3.16 108-110
    36
    Figure US20100216849A1-20100826-C00184
         		CH3
    Figure US20100216849A1-20100826-C00185
         		4.18
    37
    Figure US20100216849A1-20100826-C00186
         		CH3
    Figure US20100216849A1-20100826-C00187
         		3.63
    38
    Figure US20100216849A1-20100826-C00188
         		CH3
    Figure US20100216849A1-20100826-C00189
         		4.14
    39
    Figure US20100216849A1-20100826-C00190
         		CH3
    Figure US20100216849A1-20100826-C00191
         		4.38
    40
    Figure US20100216849A1-20100826-C00192
         		CH3
    Figure US20100216849A1-20100826-C00193
         		3.67
    41
    Figure US20100216849A1-20100826-C00194
         		CH3
    Figure US20100216849A1-20100826-C00195
         		3.48
    42
    Figure US20100216849A1-20100826-C00196
         		CH3
    Figure US20100216849A1-20100826-C00197
         		2.89
    43
    Figure US20100216849A1-20100826-C00198
         		CH3
    Figure US20100216849A1-20100826-C00199
         		4.33
    44
    Figure US20100216849A1-20100826-C00200
         		CH3
    Figure US20100216849A1-20100826-C00201
         		3.49
    45
    Figure US20100216849A1-20100826-C00202
         		CH3
    Figure US20100216849A1-20100826-C00203
         		4.90
    46
    Figure US20100216849A1-20100826-C00204
         		CH3
    Figure US20100216849A1-20100826-C00205
         		4.15
    47
    Figure US20100216849A1-20100826-C00206
         		CH3
    Figure US20100216849A1-20100826-C00207
         		4.52
    48
    Figure US20100216849A1-20100826-C00208
         		CH3
    Figure US20100216849A1-20100826-C00209
         		4.14
    49
    Figure US20100216849A1-20100826-C00210
         		CH3
    Figure US20100216849A1-20100826-C00211
         		4.92
    50
    Figure US20100216849A1-20100826-C00212
         		CH3
    Figure US20100216849A1-20100826-C00213
         		3.95
    51
    Figure US20100216849A1-20100826-C00214
         		CH3
    Figure US20100216849A1-20100826-C00215
         		4.51
    52
    Figure US20100216849A1-20100826-C00216
         		CH3
    Figure US20100216849A1-20100826-C00217
         		3.52
    53
    Figure US20100216849A1-20100826-C00218
         		CH3
    Figure US20100216849A1-20100826-C00219
         		3.53
    54
    Figure US20100216849A1-20100826-C00220
         		CH3
    Figure US20100216849A1-20100826-C00221
         		3.97
    55
    Figure US20100216849A1-20100826-C00222
         		CH3
    Figure US20100216849A1-20100826-C00223
         		3.06
    56
    Figure US20100216849A1-20100826-C00224
         		CH3
    Figure US20100216849A1-20100826-C00225
         		5.39
    57
    Figure US20100216849A1-20100826-C00226
         		CH3
    Figure US20100216849A1-20100826-C00227
         		4.41
    58
    Figure US20100216849A1-20100826-C00228
         		CH3
    Figure US20100216849A1-20100826-C00229
         		4.64
    59
    Figure US20100216849A1-20100826-C00230
         		CH3
    Figure US20100216849A1-20100826-C00231
         		4.65
    60
    Figure US20100216849A1-20100826-C00232
         		CH3
    Figure US20100216849A1-20100826-C00233
         		3.95
    61
    Figure US20100216849A1-20100826-C00234
         		CH3
    Figure US20100216849A1-20100826-C00235
         		4.98
    62
    Figure US20100216849A1-20100826-C00236
         		CH3
    Figure US20100216849A1-20100826-C00237
         		3.81
    63
    Figure US20100216849A1-20100826-C00238
         		CH3
    Figure US20100216849A1-20100826-C00239
         		4.43
    64
    Figure US20100216849A1-20100826-C00240
         		CH3
    Figure US20100216849A1-20100826-C00241
         		4.84
    65
    Figure US20100216849A1-20100826-C00242
         		CH3
    Figure US20100216849A1-20100826-C00243
         		5.05
    66
    Figure US20100216849A1-20100826-C00244
         		CH3
    Figure US20100216849A1-20100826-C00245
         		4.83
    67
    Figure US20100216849A1-20100826-C00246
         		CH3
    Figure US20100216849A1-20100826-C00247
         		3.72 108
    68
    Figure US20100216849A1-20100826-C00248
         		CH3
    Figure US20100216849A1-20100826-C00249
         		3.16 130-132
    69
    Figure US20100216849A1-20100826-C00250
         		CH3
    Figure US20100216849A1-20100826-C00251
         		3.45 113-115
    70
    Figure US20100216849A1-20100826-C00252
         		CH3
    Figure US20100216849A1-20100826-C00253
         		3.36 137-138
    71
    Figure US20100216849A1-20100826-C00254
         		CH3
    Figure US20100216849A1-20100826-C00255
         		3.27 109
    72
    Figure US20100216849A1-20100826-C00256
         		CH3
    Figure US20100216849A1-20100826-C00257
         		3.14 107
    73
    Figure US20100216849A1-20100826-C00258
         		CH3
    Figure US20100216849A1-20100826-C00259
         		3.83 140-142
    74
    Figure US20100216849A1-20100826-C00260
         		CH3
    Figure US20100216849A1-20100826-C00261
         		3.81 108-110
    75
    Figure US20100216849A1-20100826-C00262
         		CH3
    Figure US20100216849A1-20100826-C00263
         		3.6 131-133
    76
    Figure US20100216849A1-20100826-C00264
         		CH3
    Figure US20100216849A1-20100826-C00265
         		3.94 109-110
    77
    Figure US20100216849A1-20100826-C00266
         		CH3
    Figure US20100216849A1-20100826-C00267
         		3.59
    78
    Figure US20100216849A1-20100826-C00268
         		CH3
    Figure US20100216849A1-20100826-C00269
         		2.75  98-101
    79
    Figure US20100216849A1-20100826-C00270
         		CH3
    Figure US20100216849A1-20100826-C00271
         		3.81 122
    80
    Figure US20100216849A1-20100826-C00272
         		CH3
    Figure US20100216849A1-20100826-C00273
         		3.74 116-118
    81
    Figure US20100216849A1-20100826-C00274
         		CH3
    Figure US20100216849A1-20100826-C00275
         		3.73 120
    82
    Figure US20100216849A1-20100826-C00276
         		H
    Figure US20100216849A1-20100826-C00277
         		2.92 126-128
    83
    Figure US20100216849A1-20100826-C00278
         		H
    Figure US20100216849A1-20100826-C00279
         		3.48
    • Preparation of Starting Materials of the Formula (III) Example (III-1)
  • Figure US20100216849A1-20100826-C00280
  • 16.50 g (80.48 mmol) of 4-allyloxyiminomethylphenylboronic acid (V-1) and 13.84 g (80.48 mmol) of 2-bromoaniline together with 0.50 g (0.43 mmol) of tetrakis(triphenyl-phosphine)palladium are initially charged in a mixture of 100 ml of 1,2-dimethoxyethane and 100 ml of water. After addition of 34.12 g (321.92 mmol) of sodium carbonate, the mixture is heated at reflux for 12 h. For work-up, the reaction mixture is cooled to room temperature and extracted twice with in each case 200 ml of diethyl ether. The combined ether phases are washed with 400 ml of water and then dried over magnesium sulfate and concentrated under reduced pressure. The residue is chromatographed on silica gel (hexane/methyl tert-butyl ether 3:1).
  • This gives 4.3 g (15% of theory) of 2′-aminobiphenyl-4-carbaldehyde O-allyl oxime.
  • 1H-NMR (DMSO-D6): δ=8.33 ppm (s, 1H)
    • Preparation of Starting Materials of the Formula (V) Example (V-1)
  • Figure US20100216849A1-20100826-C00281
  • In a mixture of 100 ml of methanol and 40 ml of water, 13.69 g (91.28 mmol) of formylphenylboronic acid, 10.0 g of O-allylhydroxylamine hydrochloride (91.28 mmol) and 9.36 g (114.10 mmol) of sodium acetate are stirred at room temperature for 12 h. For work-up, the mixture is concentrated under reduced pressure and the residue is triturated with 150 ml of water, filtered off with suction through a glass frit, washed with a little water and dried on a clay disk.
  • This gives 16.5 g (84.6% of theory) of 4-allyloxyiminomethylphenylboronic acid.
  • 1H-NMR (DMSO-d6): δ=8.27 ppm (s, 1H)
    • Preparation of Starting Materials of the Formula (Viii) Example (VIII-1)
  • Figure US20100216849A1-20100826-C00282
  • At room temperature, 8.33 g (47.33 mmol) of 2-chloronicotinoyl chloride, dissolved in 20 ml of toluene, are added over a period of 5 minutes to 10.00 g (47.33 mmol) of 1-(2′-aminobiphenyl-4-yl)ethanone (XIV-1) and 4.79 g (47.33 mmol) of triethylamine, dissolved in 150 ml of toluene. The mixture is heated at 50° C. and allowed to react for 10 h. For work-up, the mixture is cooled, 100 ml of water are added and the phases are separated. The organic phase is dried over sodium sulfate and concentrated under reduced pressure. The residue is recrystallized from n-hexane.
  • This gives 13.7 g (82.3% of theory) of N-(4′-acetyl-biphenyl-2-yl)-2-chloronicotinamide of log P (pH 2.3)=2.12.
    • Preparation of Starting Materials of the Formula (Xiv) Example (XIV-1)
  • Figure US20100216849A1-20100826-C00283
  • 15.74 g (91.48 mmol) of 2-bromoaniline, 15.00 g of 4-acetylphenylboronic acid (91.48 mmol) and 0.529 g of tetrakis(triphenylphosphine)palladium(0) (0.457 mmol) are initially charged in 150 ml of dimethoxyethane. 38.78 g (365.93 mmol) of sodium carbonate, dissolved in 150 ml of water, are added over a period of 5 minutes. The mixture is heated at reflux temperature and stirred for 15 h. For work-up, the mixture is cooled and extracted twice with in each case 150 ml of ether. The combined organic phases are washed with water, dried over sodium sulfate and concentrated under reduced pressure.
  • The residue is purified by silica gel column chromatography (cyclohexane/ethyl acetate 3:1).
  • This gives 15.0 g (72.6% of theory) of 1-(2′-aminobiphenyl-4-yl)ethanone of log P (pH 2.3)=1.80.
  • The log P values given in Table 1 were determined with EEC Directive 79/831 Annex V.A8 by HPLC (High Performance Liquid Chromatography) on a reverse-phase column (C 18). Temperature: 43° C.
  • Mobile phases for the determination in the acidic range (pH 2.3): 0.1% aqueous phosphoric acid, acetonitrile; linear gradient from 10% acetonitrile to 90% acetonitrile. Calibration was carried out using unbranched alkan-2-ones (having 3 to 16 carbon atoms) with known log P values (determination of the log P values by the retention times using linear interpolation between two successive alkanones).
  • The lambda-max values were determined in the maxima of the chromatographic signals using the UV spectra from 200 nm to 400 nm
    • USE EXAMPLES Example A Venturia Test (Apple)/Protective
  • Solvents: 24.5 parts by weight of acetone
      • 24.5 parts by weight of dimethylacetamide
        Emulsifier: 1.0 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvents and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. After the spray coating has dried on, the plants are inoculated with an aqueous conidia suspension of the apple scab pathogen Venturia inaequalis and then remain in an incubation cabin at about 20° C. and 100% relative atmospheric humidity for 1 day.
  • The plants are then placed in a greenhouse at about 21° C. and a relative atmospheric humidity of about 90%.
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
  • In this test, for example, the following compounds according to the invention of the Preparation Examples show good activity:
  • TABLE A
    Venturia test (apple)/protective
    Active
    compound
    application rate Efficacy in
    Active compound in g/ha %
     2
    Figure US20100216849A1-20100826-C00284
         		100 98
     4
    Figure US20100216849A1-20100826-C00285
         		100 91
     6
    Figure US20100216849A1-20100826-C00286
         		100 97
     5
    Figure US20100216849A1-20100826-C00287
         		100 100
    13
    Figure US20100216849A1-20100826-C00288
         		100 100
     7
    Figure US20100216849A1-20100826-C00289
         		100 100
     8
    Figure US20100216849A1-20100826-C00290
         		100 100
     9
    Figure US20100216849A1-20100826-C00291
         		100 100
    10
    Figure US20100216849A1-20100826-C00292
         		100 100
    • Example B Botrytis Test (Bean)/Protective
  • Solvents: 24.5 parts by weight of acetone
      • 24.5 parts by weight of dimethylacetamide
        Emulsifier: 1.0 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvents and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • To test for protective activity, young plants are sprayed with the preparation of active compound at the stated application rate. After the spray coating has dried on, 2 small pieces of agar colonized by Botrytis cinerea are placed onto each leaf. The inoculated plants are placed in a dark chamber at about 20° C. and 100% relative atmospheric humidity.
  • 2 days after the inoculation, the size of the infected areas on the leaves is evaluated. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
  • In this test, for example, the following compounds according to the invention of the Preparation Examples show good activity:
  • TABLE B
    Botrytis test (bean)/protective
    Active
    compound
    application rate Efficacy in
    Active compound in g/ha %
     2
    Figure US20100216849A1-20100826-C00293
         		500 98
     3
    Figure US20100216849A1-20100826-C00294
         		500 95
     6
    Figure US20100216849A1-20100826-C00295
         		500 98
     5
    Figure US20100216849A1-20100826-C00296
         		500 83
    13
    Figure US20100216849A1-20100826-C00297
         		500 100
     7
    Figure US20100216849A1-20100826-C00298
         		500 96
     8
    Figure US20100216849A1-20100826-C00299
         		500 85
     9
    Figure US20100216849A1-20100826-C00300
         		500 95
    10
    Figure US20100216849A1-20100826-C00301
         		500 95
    • Example C Alternaria Test (Tomato)/Protective
  • Solvent: 49 parts by weight of N,N-dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • To test for protective activity, young tomato plants are sprayed with the preparation of active compound at the stated application rate. 1 day after the treatment, the plants are inoculated with a spore suspension of Alternaria solani and then remain at 100% relative atmospheric humidity and 20° C. for 24 hours. The plants then remain at 96% relative atmospheric humidity and a temperature of 20° C.
  • Evaluation is carried out 7 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
  • In this test, for example, the following compounds according to the invention of the Preparation Examples show good activity:
  • TABLE C
    Alternaria test (tomato)/protective
    Active
    compound
    application rate Efficacy in
    Active compound in g/ha %
     1
    Figure US20100216849A1-20100826-C00302
         		750 90
     2
    Figure US20100216849A1-20100826-C00303
         		750 90
     6
    Figure US20100216849A1-20100826-C00304
         		750 100
     5
    Figure US20100216849A1-20100826-C00305
         		750 100
    11
    Figure US20100216849A1-20100826-C00306
         		750 100
    12
    Figure US20100216849A1-20100826-C00307
         		750 100
    • Example D Puccinia Test (Wheat)/Protective
  • Solvents: 25 parts by weight of N,N-dimethylacetamide
    Emulsifier: 0.6 parts by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amounts of solvent and emulsifier, and the concentrate is diluted with water to the desired concentration.
  • To test for protective activity, young plants are inoculated with a spore suspension of Puccinia recondita in a 0.1% strength aqueous agar solution. After the spray coating has dried on, the plants are sprayed with the preparation of active compound at the stated application rate. The plants remain in an incubation cabin at 20° C. and 100% relative atmospheric humidity for 24 hours.
  • The plants are then placed in a greenhouse at a temperature of about 20° C. and a relative atmospheric humidity of 80% to promote the development of rust pustules.
  • Evaluation is carried out 10 days after the inoculation. 0% means an efficacy which corresponds to that of the control, whereas an efficacy of 100% means that no infection is observed.
  • In this test, for example, the following compounds according to the invention of the Preparation Examples show good activity:
  • TABLE D
    Puccinia test (wheat)/protective
    Active
    compound
    application rate Efficacy in
    Active compound in g/ha %
     1
    Figure US20100216849A1-20100826-C00308
         		500 100
     6
    Figure US20100216849A1-20100826-C00309
         		500 100
     7
    Figure US20100216849A1-20100826-C00310
         		500 100
    10
    Figure US20100216849A1-20100826-C00311
         		500 100
    15
    Figure US20100216849A1-20100826-C00312
         		500 100
    40
    Figure US20100216849A1-20100826-C00313
         		500 100
    55
    Figure US20100216849A1-20100826-C00314
         		500 100
    69
    Figure US20100216849A1-20100826-C00315
         		500 100
    72
    Figure US20100216849A1-20100826-C00316
         		500 100
    • Example E Plutella Test
  • Solvents: 100 parts by weight of acetone
      • 1900 parts by weight of methanol
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent, and the concentrate is diluted with methanol to the desired concentrations.
  • A stated amount of the preparation of active compound of the desired concentration is pipetted onto a standardized amount of synthetic feed. After the methanol has evaporated, about 200-300 eggs of the diamond back moth (Plutella xylostella) are placed onto the feed.
  • After the desired period of time, the kill of the eggs in % is determined 100% means that all animals have been killed; 0% means that none of the animals have been killed.
  • In this test, for example, the following compounds of the Preparation Examples show good activity:
  • TABLE E
    Plutella test
    Active
    compound con- Kill rate
    centration in in %
    Active compound ppm after 7d
    15
    Figure US20100216849A1-20100826-C00317
         		1000 95
    22
    Figure US20100216849A1-20100826-C00318
         		1000 95

Claims (14)

1-14. (canceled)
15. A biphenylcarboxamide of formula (I)
Figure US20100216849A1-20100826-C00319
in which
R represents hydrogen or C1-C6-alkyl; or represents C1-C3-haloalkyl having 1 to 7 fluorine, chlorine, and/or bromine atoms,
Z represents C3-C8-alkenyl or C3-C8-alkynyl; represents C3-C8-haloalkenyl or C3-C8-haloalkynyl having 1 to 5 fluorine, chlorine, and/or bromine atoms; or represents (C3-C8-cycloalkyl)(C1-C4-alkyl),
X and Y independently of one another represent halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, or C1-C8-alkylthio, or represent C1-C8-haloalkyl, C1-C8-haloalkoxy, or C1-C6-haloalkylthio having 1 to 13 fluorine, chlorine, and/or bromine atoms,
m represents 0, 1, 2, 3, or 4, with the proviso that X represents identical or different radicals when m represents 2, 3, or 4,
n represents 0, 1, 2, 3, or 4, with the proviso that Y represents identical or different radicals when n represents 2, 3, or 4, and
A represents
(ii) a radical of the formula
Figure US20100216849A1-20100826-C00320
in which
R4 and R5 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R6 represents halogen, cyano or C1-C4-alkyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(iii) a radical of the formula
Figure US20100216849A1-20100826-C00321
in which
R7 and R8 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R9 represents hydrogen, halogen, or C1-C4-alkyl,
or
(iv) a radical of the formula
Figure US20100216849A1-20100826-C00322
in which R19 represents hydrogen, halogen, hydroxyl, cyano, or C1-C6-alkyl; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-halo-alkylthio having 1 to 5 halogen atoms,
or
(v) a radical of the formula
Figure US20100216849A1-20100826-C00323
in which
R11 represents halogen, hydroxyl, cyano, C1-C4-alkyl, C1-C4-alkoxy, or C1-C4-alkylthio; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms, and
R12 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfinyl, or C1-C4-alkylsulfonyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(vi) a radical of the formula
Figure US20100216849A1-20100826-C00324
in which
R13 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
R14 represents C1-C4-alkyl,
X1 represents S, SO, SO2, or CH2, and
p represents 0, 1, or 2,
or
(vii) a radical of the formula
Figure US20100216849A1-20100826-C00325
in which R15 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(viii) a radical of the formula
Figure US20100216849A1-20100826-C00326
in which R16 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(x) a radical of the formula
Figure US20100216849A1-20100826-C00327
in which
R20 and R21 independently of one another represent hydrogen, halogen, amino, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R22 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xi) a radical of the formula
Figure US20100216849A1-20100826-C00328
in which
R23 and R24 independently of one another represent hydrogen, halogen, amino, nitro, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R25 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xvi) a radical of the formula
Figure US20100216849A1-20100826-C00329
in which R33 represents C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xvii) a radical of the formula
Figure US20100216849A1-20100826-C00330
in which R34 represents hydrogen, halogen, C1-C4-alkyl, or C1-C2-haloalkyl having 1 to 5 halogen atoms.
16. A biphenylcarboxamide of formula (I) as claimed in claim 15 in which
R represents hydrogen, C1-C4-alkyl, or C1-C3-haloalkyl having 1 to 7 fluorine, chlorine, and/or bromine atoms,
Z represents C3-C6-alkenyl or C3-C6-alkynyl; represents C3-C6-haloalkenyl or C3-C6-haloalkynyl having 1 to 5 fluorine, chlorine, and/or bromine atoms; or represents (C3-C6-cycloalkyl)-(C1-C4-alkyl),
X and Y independently of one another represent fluorine, chlorine, bromine, cyano, nitro, C1-C6-alkyl, C1-C6-alkoxy, or C1-C6-alkylthio, or represent C1-C2-haloalkyl, C1-C2-haloalkoxy, or C1-C2-haloalkylthio having 1 to 5 fluorine, chlorine, and/or bromine atoms,
m represents 0, 1, 2, or 3, with the proviso that X represents identical or different radicals when m represents 2 or 3,
n represents 0, 1, 2, or 3, with the proviso that Y represents identical or different radicals when m represents 2 or 3, and
A represents
(ii) a radical of the formula
Figure US20100216849A1-20100826-C00331
in which
R4 and R5 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms, and
R6 represents fluorine, chlorine, bromine, iodine, cyano, methyl, ethyl, trifluoromethyl, or C1-C2-haloalkoxy having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(iii) a radical of the formula
Figure US20100216849A1-20100826-C00332
in which
R7 and R8 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms, and
R9 represents hydrogen, fluorine, chlorine, bromine, methyl, or ethyl,
or
(iv) a radical of the formula
Figure US20100216849A1-20100826-C00333
in which R10 represents hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, or C1-C4-alkyl; or represents C1-C2-haloalkyl, C1-C2-haloalkoxy, or C1-C2-haloalkylthio having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(v) a radical of the formula
Figure US20100216849A1-20100826-C00334
in which
R11 represents fluorine, chlorine, bromine, iodine, hydroxyl, cyano, C1-C4-alkyl, methoxy, ethoxy, methylthio, or ethylthio; represents C1-C2-haloalkyl or C1-C2-haloalkoxy having 1 to 5 fluorine, chlorine, and/or bromine atoms; or represents trifluoromethylthio or difluoromethylthio, and
R12 represents hydrogen, fluorine, chlorine, bromine, iodine, cyano, C1-C4-alkyl, methoxy, ethoxy, methylthio, ethylthio, C1-C2-alkyl-sulfinyl, or C1-C2-alkylsulfonyl; or represents C1-C2-haloalkyl or C1-C2-haloalkoxy having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(vi) a radical of the formula
Figure US20100216849A1-20100826-C00335
in which
R13 represents methyl or ethyl, or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms,
R14 represents methyl or ethyl,
X1 represents S, SO, SO2, or CH2, and
p represents 0, 1, or 2,
or
(vii) a radical of the formula
Figure US20100216849A1-20100826-C00336
in which R15 represents methyl or ethyl, or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(viii) a radical of the formula
Figure US20100216849A1-20100826-C00337
in which R16 represents methyl or ethyl, or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(x) a radical of the formula
Figure US20100216849A1-20100826-C00338
in which
R20 and R21 independently of one another represent hydrogen, fluorine, chlorine, bromine, amino, methyl, or ethyl, or represent C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms, and
R22 represents hydrogen, fluorine, chlorine, bromine, methyl, or ethyl, or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(xi) a radical of the formula
Figure US20100216849A1-20100826-C00339
in which
R23 and R24 independently of one another represent hydrogen, fluorine, chlorine, bromine, amino, nitro, methyl, or ethyl, or represent C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms, and
R25 represents hydrogen, fluorine, chlorine, bromine, methyl, or ethyl, or represents C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(xvi) a radical of the formula
Figure US20100216849A1-20100826-C00340
in which
R33 represents methyl, ethyl, or C1-C2-haloalkyl having 1 to 5 fluorine, chlorine, and/or bromine atoms,
or
(xvii) a radical of the formula
Figure US20100216849A1-20100826-C00341
in which
R34 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, or trifluoromethyl.
17. A biphenylcarboxamide of formula (I) as claimed in claim 15 in which
R represents hydrogen, methyl, ethyl, isopropyl, or tert-butyl,
Z represents allyl, 2-butenyl, 2-methylallyl, 1-methylallyl, 3-methyl-2-butenyl, propargyl, 2-butynyl, 3-butynyl, 2-methyl-3-butynyl, 3,3-difluoroallyl, 3,3-dichloroallyl, cyclopropylmethyl, cyclopentylmethyl, or cyclohexylmethyl,
X and Y independently of one another represent fluorine, chlorine, bromine, cyano, nitro, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, methoxy, ethoxy, methylthio, trichloromethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, difluoromethoxy, trifluoromethoxy, trifluoromethylthio, or difluorochloromethylthio,
m represents 0 or 1,
n represents 0, 1, or 2, with the proviso that Y represents identical or different radicals when n represents 2, and
A represents
(ii) a radical of the formula
Figure US20100216849A1-20100826-C00342
in which
R4 and R5 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl, or trichloromethyl, and
R6 represents fluorine, chlorine, bromine, cyano, methyl, trifluoro-methyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, or trichloromethoxy,
or
(iii) a radical of the formula
Figure US20100216849A1-20100826-C00343
in which
R7 and R8 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, difluoromethyl, trifluoromethyl, difluorochloromethyl, or trichloromethyl, and
R9 represents hydrogen, fluorine, chlorine, bromine, methyl, or ethyl,
or
(iv) a radical of the formula
Figure US20100216849A1-20100826-C00344
in which R19 represents hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, difluoromethyl, trifluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, trichloromethoxy, trifluoromethylthio, difluoromethylthio, difluorochloromethylthio, or trichloromethylthio,
or
(v) a radical of the formula
Figure US20100216849A1-20100826-C00345
in which
R11 represents fluorine, chlorine, bromine, iodine, hydroxyl, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, methoxy, ethoxy, methylthio, ethylthio, trifluoromethyl, difluoromethyl, difluorochloromethyl, trichloromethyl, trifluoro-methoxy, difluoromethoxy, difluorochloromethoxy, trichloromethoxy, difluoromethylthio, or trifluoromethylthio, and
R12 represents hydrogen, fluorine, chlorine, bromine, iodine, cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, methoxy, ethoxy, methylthio, ethylthio, methylsulfinyl, methylsulfonyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, trichloromethyl, trifluoromethoxy, difluoromethoxy, difluorochloromethoxy, or trichloromethoxy,
or
(vi) a radical of the formula
Figure US20100216849A1-20100826-C00346
in which
R13 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, or trichloromethyl,
R14 represents methyl or ethyl,
X1 represents S, SO, SO2, or CH2, and
p represents 0, 1, or 2,
or
(vii) a radical of the formula
Figure US20100216849A1-20100826-C00347
in which R15 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, or trichloromethyl,
or
(viii) a radical of the formula
Figure US20100216849A1-20100826-C00348
in which R16 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, or trichloromethyl,
or
(x) a radical of the formula
Figure US20100216849A1-20100826-C00349
in which
R20 and R21 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, or trichloromethyl, and
R22 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, or trichloro-methyl,
or
(xi) a radical of the formula
Figure US20100216849A1-20100826-C00350
in which
R23 and R24 independently of one another represent hydrogen, fluorine, chlorine, bromine, nitro, methyl, ethyl, trifluoromethyl, difluoro-methyl, difluorochloromethyl, or trichloromethyl, and
R25 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, or trichloro-methyl,
or
(xvi) a radical of the formula
Figure US20100216849A1-20100826-C00351
in which R33 represents methyl, ethyl, trifluoromethyl, difluoromethyl, difluorochloromethyl, or trichloromethyl,
or
(xvii) a radical of the formula
Figure US20100216849A1-20100826-C00352
in which R34 represents hydrogen, fluorine, chlorine, bromine, methyl, ethyl, or trifluoromethyl.
18. A biphenylcarboxamide as claimed in claim 15 having formula (I-1)
Figure US20100216849A1-20100826-C00353
in which R, Z, X, Y, m, n, and A are as defined for formula (I) in claim 15.
19. A process for preparing a biphenylcarboxamide having the formula
Figure US20100216849A1-20100826-C00354
in which
R represents hydrogen or C1-C6-alkyl; or represents C1-C3-haloalkyl having 1 to 7 fluorine, chlorine, and/or bromine atoms,
Z represents C3-C8-alkenyl or C3-C8-alkynyl; represents C3-C8-haloalkenyl or C3-C8-haloalkynyl having 1 to 5 fluorine, chlorine, and/or bromine atoms; or represents (C3-C8-cycloalkyl)(C1-C4-alkyl),
X and Y independently of one another represent halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, or C1-C8-alkylthio, or represent C1-C6-haloalkyl, C1-C6-haloalkoxy, or C1-C6-haloalkylthio having 1 to 13 fluorine, chlorine, and/or bromine atoms,
m represents 0, 1, 2, 3, or 4, with the proviso that X represents identical or different radicals when m represents 2, 3, or 4,
n represents 0, 1, 2, 3, or 4, with the proviso that Y represents identical or different radicals when n represents 2, 3, or 4, and
A represents
(i) a radical of the formula
Figure US20100216849A1-20100826-C00355
in which
R1 represents hydrogen, cyano, halogen, nitro, C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, amino-carbonyl, or aminocarbonyl-C1-C4-alkyl; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms,
R2 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy, or C1-C4-alkylthio, and
R3 represents hydrogen, C1-C4-alkyl, hydroxy-C1-C4-alkyl, C2-C6-alkenyl, C3-C6-cycloalkyl, C1-C4-alkylthio-C1-C4-alkyl, or C1-C4-alkoxy-C1-C4-alkyl; represents C1-C4-haloalkyl, halo(C1-C4-alkylthio-C1-C4-alkyl), or halo(C1-C4-alkoxy-C1-C4-alkyl) having 1 to 5 halogen atoms; or represents phenyl,
or
(ii) a radical of the formula
Figure US20100216849A1-20100826-C00356
in which
R4 and R5 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R6 represents halogen, cyano or C1-C4-alkyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(iii) a radical of the formula
Figure US20100216849A1-20100826-C00357
in which
R7 and R8 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R9 represents hydrogen, halogen, or C1-C4-alkyl,
or
(iv) a radical of the formula
Figure US20100216849A1-20100826-C00358
in which R10 represents hydrogen, halogen, hydroxyl, cyano, or C1-C6-alkyl; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms,
or
(v) a radical of the formula
Figure US20100216849A1-20100826-C00359
in which
R11 represents halogen, hydroxyl, cyano, C1-C4-alkyl, C1-C4-alkoxy, or C1-C4-alkylthio; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms, and
R12 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfinyl, or C1-C4-alkyl-sulfonyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(vi) a radical of the formula
Figure US20100216849A1-20100826-C00360
in which
R13 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
R14 represents C1-C4-alkyl,
X1 represents S, SO, SO2, or CH2, and
p represents 0, 1, or 2,
or
(vii) a radical of the formula
Figure US20100216849A1-20100826-C00361
in which R15 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(viii) a radical of the formula
Figure US20100216849A1-20100826-C00362
in which R16 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(ix) a radical of the formula
Figure US20100216849A1-20100826-C00363
in which
R17 represents halogen, cyano, C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
R18 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R19 represents hydrogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl having 1 to 5 halogen atoms, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkysulfonyl, di(C1-C4-alkyl)-aminosulfonyl, C1-C6-alkylcarbonyl; or represents optionally substituted phenylsulfonyl or benzoyl,
or
(x) a radical of the formula
Figure US20100216849A1-20100826-C00364
in which
R20 and R21 independently of one another represent hydrogen, halogen, amino, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R22 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xi) a radical of the formula
Figure US20100216849A1-20100826-C00365
in which
R23 and R24 independently of one another represent hydrogen, halogen, amino, nitro, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R25 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xii) a radical of the formula
Figure US20100216849A1-20100826-C00366
in which
R26 represents hydrogen, halogen, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, cyano, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R27 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xiii) a radical of the formula
Figure US20100216849A1-20100826-C00367
in which
R28 represents hydrogen, halogen, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, cyano, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R29 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xiv) a radical of the formula
Figure US20100216849A1-20100826-C00368
in which R30 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xv) a radical of the formula
Figure US20100216849A1-20100826-C00369
in which
R31 represents hydrogen or C1-C4-alkyl, and
R32 represents halogen or C1-C4-alkyl,
or
(xvi) a radical of the formula
Figure US20100216849A1-20100826-C00370
in which R33 represents C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xvii) a radical of the formula
Figure US20100216849A1-20100826-C00371
in which R34 represents hydrogen, halogen, C1-C4-alkyl, or C1-C2-haloalkyl having 1 to 5 halogen atoms,
comprising
(a) reacting a carboxylic acid derivative of formula (II)
Figure US20100216849A1-20100826-C00372
in which
A is as defined above, and
G represents halogen, hydroxyl, or C1-C6-alkoxy,
with an aniline derivative of formula (III)
Figure US20100216849A1-20100826-C00373
in which R, Z, X, Y, m, and n are as defined above,
optionally in the presence of a catalyst, optionally in the presence of an acid binder, and optionally in the presence of a diluent,
or
(b) reacting a carboxamide derivative of formula (IV)
Figure US20100216849A1-20100826-C00374
in which
A, X, and m are as defined above, and
Hal1 represents bromine or iodine,
with a boronic acid derivative of formula (V)
Figure US20100216849A1-20100826-C00375
in which
R, Z, Y, and n are as defined above, and
G1 and G2 each represent hydrogen or together represent tetramethylethylene,
in the presence of a catalyst, optionally in the presence of an acid binder, and optionally in the presence of a diluent,
or
(c) reacting a carboxamide boronic acid derivative of formula (VI)
Figure US20100216849A1-20100826-C00376
in which
A, X, and m are as defined above, and
G1 and G2 each represent hydrogen or together represent tetramethylethylene,
with a phenyl oxime derivative of formula (VII)
Figure US20100216849A1-20100826-C00377
in which
R, Z, Y, and n are as defined above, and
Hal1 represents bromine or iodine,
in the presence of a catalyst, optionally in the presence of an acid binder, and optionally in the presence of a diluent,
or
(d) reacting a biphenylacyl derivative of formula (VIII)
Figure US20100216849A1-20100826-C00378
in which A, R, X, Y, m, and n are as defined above, with a hydroxylamine derivative of formula (IX)

Z—O—NH2×HCl  (IX)
in which Z is as defined above,
optionally in the presence of an acid binder and optionally in the presence of a diluent,
or
(e) reacting a hydroxyimino derivative of formula (I-a)
Figure US20100216849A1-20100826-C00379
in which A, R, X, Y, m, and n are as defined above,
with a compound of formula (X)

Z-E  (X)
in which
Z is as defined above, and
E represents chlorine, bromine, iodine, methanesulfonyl, or p-toluenesulfonyl,
optionally in the presence of an acid binder and optionally in the presence of a diluent,
or
(f) reacting a carboxamide derivative of formula (IV)
Figure US20100216849A1-20100826-C00380
in which
A, X, and m are as defined above, and
Hal1 represents bromine or iodine,
with a phenyl oxime derivative of formula (VII)
Figure US20100216849A1-20100826-C00381
in which
R, Z, Y, and n are as defined above, and
Hal1 represents bromine or iodine,
in the presence of a palladium or platinum catalyst and in the presence of 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bis-1,3,2-dioxaborolane, optionally in the presence of an acid binder, and optionally in the presence of a diluent.
20. A composition for controlling unwanted microorganisms comprising one or more biphenylcarboxamides of formula (I) as claimed in claim 15 and one or more extenders and/or surfactants.
21. A method for controlling unwanted microorganisms comprising applying an effective amount of one or more biphenylcarboxamides of formula (I) as claimed in claim 15 to the microorganisms and/or their habitat.
22. A process for preparing compositions for controlling unwanted microorganisms comprising mixing one or more biphenylcarboxamides of the formula (I) according to claim 15 with one or more extenders and/or surfactants.
23. An aniline derivative of formula (III)
Figure US20100216849A1-20100826-C00382
in which
R represents hydrogen or C1-C6-alkyl; or represents C1-C3-haloalkyl having 1 to 7 fluorine, chlorine, and/or bromine atoms,
Z represents C3-C8-alkenyl or C3-C8-alkynyl; represents C3-C8-haloalkenyl or C3-C8-haloalkynyl having 1 to 5 fluorine, chlorine, and/or bromine atoms; or represents (C3-C8-cycloalkyl)(C1-C4-alkyl),
X and Y independently of one another represent halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, or C1-C8-alkylthio, or represent C1-C6-haloalkyl, C1-C6-haloalkoxy, or C1-C6-haloalkylthio having 1 to 13 fluorine, chlorine, and/or bromine atoms,
m represents 0, 1, 2, 3, or 4, with the proviso that X represents identical or different radicals when m represents 2, 3, or 4, and
n represents 0, 1, 2, 3, or 4, with the proviso that Y represents identical or different radicals when n represents 2, 3, or 4.
24. A boronic acid derivative of formula (V)
Figure US20100216849A1-20100826-C00383
in which
R represents hydrogen or C1-C6-alkyl; or represents C1-C3-haloalkyl having 1 to 7 fluorine, chlorine, and/or bromine atoms,
Z represents C3-C8-alkenyl or C3-C8-alkynyl; represents C3-C8-haloalkenyl or C3-C8-haloalkynyl having 1 to 5 fluorine, chlorine, and/or bromine atoms; or represents (C3-C8-cycloalkyl)(C1-C4-alkyl),
Y represents halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, or C1-C8-alkylthio, or represent C1-C6-haloalkyl, C1-C6-haloalkoxy, or C1-C6-haloalkylthio having 1 to 13 fluorine, chlorine, and/or bromine atoms,
n represents 0, 1, 2, 3, or 4, with the proviso that Y represents identical or different radicals when n represents 2, 3, or 4, and
G1 and G2 each represent hydrogen or together represent tetramethylethylene.
25. A carboxamide boronic acid derivative of formula (VI)
Figure US20100216849A1-20100826-C00384
in which
G1 and G2 each represent hydrogen or together represent tetramethylethylene,
X represents halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, or C1-C8-alkylthio, or represent C1-C6-haloalkyl, C1-C6-haloalkoxy, or C1-C6-haloalkylthio having 1 to 13 fluorine, chlorine, and/or bromine atoms,
m represents 0, 1, 2, 3, or 4, with the proviso that X represents identical or different radicals when m represents 2, 3, or 4, and
A represents
(i) a radical of the formula
Figure US20100216849A1-20100826-C00385
in which
R1 represents hydrogen, cyano, halogen, nitro, C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, aminocarbonyl, or aminocarbonyl-C1-C4-alkyl; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms,
R2 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy, or C1-C4-alkylthio, and
R3 represents hydrogen, C1-C4-alkyl, hydroxy-C1-C4-alkyl, C2-C6-alkenyl, C3-C6-cycloalkyl, C1-C4-alkylthio-C1-C4-alkyl, or C1-C4-alkoxy-C1-C4-alkyl; represents C1-C4-haloalkyl, halo(C1-C4-alkylthio-C1-C4-alkyl), or halo(C1-C4-alkoxy-C1-C4-alkyl) having 1 to 5 halogen atoms; or represents phenyl,
or
(ii) a radical of the formula
Figure US20100216849A1-20100826-C00386
in which
R4 and R5 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R6 represents halogen, cyano or C1-C4-alkyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(iii) a radical of the formula
Figure US20100216849A1-20100826-C00387
in which
R7 and R8 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R9 represents hydrogen, halogen, or C1-C4-alkyl,
or
(iv) a radical of the formula
Figure US20100216849A1-20100826-C00388
in which R10 represents hydrogen, halogen, hydroxyl, cyano, or C1-C6-alkyl; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-halo-alkylthio having 1 to 5 halogen atoms,
or
(v) a radical of the formula
Figure US20100216849A1-20100826-C00389
in which
R11 represents halogen, hydroxyl, cyano, C1-C4-alkyl, C1-C4-alkoxy, or C1-C4-alkylthio; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms, and
R12 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfinyl, or C1-C4-alkylsulfonyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(vi) a radical of the formula
Figure US20100216849A1-20100826-C00390
in which
R13 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
R14 represents C1-C4-alkyl,
X1 represents S, SO, SO2, or CH2, and
p represents 0, 1, or 2,
or
(vii) a radical of the formula
Figure US20100216849A1-20100826-C00391
in which R15 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(viii) a radical of the formula
Figure US20100216849A1-20100826-C00392
in which R16 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(ix) a radical of the formula
Figure US20100216849A1-20100826-C00393
in which
R17 represents halogen, cyano, C1-C4-alkyl or represents C1-C4-halo-alkyl having 1 to 5 halogen atoms,
R18 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R19 represents hydrogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl having 1 to 5 halogen atoms, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkysulfonyl, di(C1-C4-alkyl)aminosulfonyl, C1-C6-alkyl-carbonyl; or represents optionally substituted phenylsulfonyl or benzoyl,
or
(x) a radical of the formula
Figure US20100216849A1-20100826-C00394
in which
R20 and R21 independently of one another represent hydrogen, halogen, amino, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R22 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xi) a radical of the formula
Figure US20100216849A1-20100826-C00395
in which
R23 and R24 independently of one another represent hydrogen, halogen, amino, nitro, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R25 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xii) a radical of the formula
Figure US20100216849A1-20100826-C00396
in which
R26 represents hydrogen, halogen, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, cyano, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R27 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xiii) a radical of the formula
Figure US20100216849A1-20100826-C00397
in which
R28 represents hydrogen, halogen, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, cyano, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R29 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xiv) a radical of the formula
Figure US20100216849A1-20100826-C00398
in which R30 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xv) a radical of the formula
Figure US20100216849A1-20100826-C00399
in which
R31 represents hydrogen or C1-C4-alkyl, and
R32 represents halogen or C1-C4-alkyl,
or
(xvi) a radical of the formula
Figure US20100216849A1-20100826-C00400
in which R33 represents C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xvii) a radical of the formula
Figure US20100216849A1-20100826-C00401
in which R34 represents hydrogen, halogen, C1-C4-alkyl, or C1-C2-haloalkyl having 1 to 5 halogen atoms.
26. A biphenylacyl derivative of formula (VIII)
Figure US20100216849A1-20100826-C00402
in which
R represents hydrogen or C1-C6-alkyl; or represents C1-C3-haloalkyl having 1 to 7 fluorine, chlorine, and/or bromine atoms,
X and Y independently of one another represent halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, or C1-C8-alkylthio, or represent C1-C6-haloalkyl, C1-C6-haloalkoxy, or C1-C6-haloalkylthio having 1 to 13 fluorine, chlorine, and/or bromine atoms,
m represents 0, 1, 2, 3, or 4, with the proviso that X represents identical or different radicals when m represents 2, 3, or 4,
n represents 0, 1, 2, 3, or 4, with the proviso that Y represents identical or different radicals when n represents 2, 3, or 4, and
A represents
(i) a radical of the formula
Figure US20100216849A1-20100826-C00403
in which
R1 represents hydrogen, cyano, halogen, nitro, C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C1-C4-alkylthio, aminocarbonyl, or aminocarbonyl-C1-C4-alkyl; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms,
R2 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy, or C1-C4-alkylthio, and
R3 represents hydrogen, C1-C4-alkyl, hydroxy-C1-C4-alkyl, C2-C6-alkenyl, C3-C6-cycloalkyl, C1-C4-alkylthio-C1-C4-alkyl, or C1-C4-alkoxy-C1-C4-alkyl; represents C1-C4-haloalkyl, halo(C1-C4-alkylthio-C1-C4-alkyl), or halo(C1-C4-alkoxy-C1-C4-alkyl) having 1 to 5 halogen atoms; or represents phenyl,
or
(ii) a radical of the formula
Figure US20100216849A1-20100826-C00404
in which
R4 and R5 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R6 represents halogen, cyano or C1-C4-alkyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(iii) a radical of the formula
Figure US20100216849A1-20100826-C00405
in which
R7 and R8 independently of one another represent hydrogen, halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R9 represents hydrogen, halogen, or C1-C4-alkyl,
or
(iv) a radical of the formula
Figure US20100216849A1-20100826-C00406
in which R10 represents hydrogen, halogen, hydroxyl, cyano, or C1-C6-alkyl; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-halo-alkylthio having 1 to 5 halogen atoms,
or
(v) a radical of the formula
Figure US20100216849A1-20100826-C00407
in which
R11 represents halogen, hydroxyl, cyano, C1-C4-alkyl, C1-C4-alkoxy, or C1-C4-alkylthio; or represents C1-C4-haloalkyl, C1-C4-haloalkoxy, or C1-C4-haloalkylthio having 1 to 5 halogen atoms, and
R12 represents hydrogen, halogen, cyano, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C1-C4-alkylsulfinyl, or C1-C4-alkylsulfonyl; or represents C1-C4-haloalkyl or C1-C4-haloalkoxy having 1 to 5 halogen atoms,
or
(vi) a radical of the formula
Figure US20100216849A1-20100826-C00408
in which
R13 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
R14 represents C1-C4-alkyl,
X1 represents S, SO, SO2, or CH2, and
p represents 0, 1, or 2,
or
(vii) a radical of the formula
Figure US20100216849A1-20100826-C00409
in which R15 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(viii) a radical of the formula
Figure US20100216849A1-20100826-C00410
in which R16 represents C1-C4-alkyl or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(ix) a radical of the formula
Figure US20100216849A1-20100826-C00411
in which
R17 represents halogen, cyano, C1-C4-alkyl or represents C1-C4-halo-alkyl having 1 to 5 halogen atoms,
R18 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R19 represents hydrogen, cyano, C1-C4-alkyl, C1-C4-haloalkyl having 1 to 5 halogen atoms, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkysulfonyl, di(C1-C4-alkyl)aminosulfonyl, C1-C6-alkyl-carbonyl; or represents optionally substituted phenylsulfonyl or benzoyl,
or
(x) a radical of the formula
Figure US20100216849A1-20100826-C00412
in which
R20 and R21 independently of one another represent hydrogen, halogen, amino, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R22 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xi) a radical of the formula
Figure US20100216849A1-20100826-C00413
in which
R23 and R24 independently of one another represent hydrogen, halogen, amino, nitro, or C1-C4-alkyl or represent C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R25 represents hydrogen, halogen, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xii) a radical of the formula
Figure US20100216849A1-20100826-C00414
in which
R26 represents hydrogen, halogen, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, cyano, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R27 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xiii) a radical of the formula
Figure US20100216849A1-20100826-C00415
in which
R28 represents hydrogen, halogen, amino, C1-C4-alkylamino, di(C1-C4-alkyl)amino, cyano, or C1-C4-alkyl; or represents C1-C4-haloalkyl having 1 to 5 halogen atoms, and
R29 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xiv) a radical of the formula
Figure US20100216849A1-20100826-C00416
in which R30 represents halogen, C1-C4-alkyl, or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xv) a radical of the formula
Figure US20100216849A1-20100826-C00417
in which
R31 represents hydrogen or C1-C4-alkyl, and
R32 represents halogen or C1-C4-alkyl,
or
(xvi) a radical of the formula
Figure US20100216849A1-20100826-C00418
in which R33 represents C1-C4-alkyl or C1-C4-haloalkyl having 1 to 5 halogen atoms,
or
(xvii) a radical of the formula
Figure US20100216849A1-20100826-C00419
in which R34 represents hydrogen, halogen, C1-C4-alkyl, or C1-C2-haloalkyl having 1 to 5 halogen atoms.
27. A 2-benzaldehyde aniline derivative of formula (XIV)
Figure US20100216849A1-20100826-C00420
in which
R represents hydrogen or C1-C6-alkyl; or represents C1-C3-haloalkyl having 1 to 7 fluorine, chlorine, and/or bromine atoms,
X and Y independently of one another represent halogen, cyano, nitro, C1-C8-alkyl, C1-C8-alkoxy, or C1-C8-alkylthio, or represent C1-C6-haloalkyl, C1-C6-haloalkoxy, or C1-C6-haloalkylthio having 1 to 13 fluorine, chlorine, and/or bromine atoms,
m represents 0, 1, 2, 3, or 4, with the proviso that X represents identical or different radicals when m represents 2, 3, or 4, and
n represents 0, 1, 2, 3, or 4, with the proviso that Y represents identical or different radicals when n represents 2, 3, or 4.
US12/771,285 2002-12-13 2010-04-30 Biphenylcarboxamides Abandoned US20100216849A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/771,285 US20100216849A1 (en) 2002-12-13 2010-04-30 Biphenylcarboxamides

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10258314A DE10258314A1 (en) 2002-12-13 2002-12-13 New alkoxyimino-substituted biphenylcarboxamide derivatives, useful as pesticides, antimicrobials, herbicides and antimycotics, also their new intermediates
DE10258314.5 2002-12-13
PCT/EP2003/013498 WO2004054982A1 (en) 2002-12-13 2003-12-01 Biphenylcarboxamides
US53824207A 2007-03-23 2007-03-23
US12/771,285 US20100216849A1 (en) 2002-12-13 2010-04-30 Biphenylcarboxamides

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2003/013498 Division WO2004054982A1 (en) 2002-12-13 2003-12-01 Biphenylcarboxamides
US53824207A Division 2002-12-13 2007-03-23

Publications (1)

Publication Number Publication Date
US20100216849A1 true US20100216849A1 (en) 2010-08-26

Family

ID=32336291

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/538,242 Expired - Fee Related US7728019B2 (en) 2002-12-13 2003-12-01 Biphenylcarboxamides
US12/771,285 Abandoned US20100216849A1 (en) 2002-12-13 2010-04-30 Biphenylcarboxamides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/538,242 Expired - Fee Related US7728019B2 (en) 2002-12-13 2003-12-01 Biphenylcarboxamides

Country Status (8)

Country Link
US (2) US7728019B2 (en)
EP (1) EP1572663B1 (en)
JP (1) JP4555085B2 (en)
CN (1) CN100391947C (en)
AU (1) AU2003298156A1 (en)
BR (1) BR0317290B1 (en)
DE (1) DE10258314A1 (en)
WO (1) WO2004054982A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9765034B2 (en) 2012-05-09 2017-09-19 Bayer Cropscience Ag 5-halogenopyrazole biphenylcarboxamides

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10354607A1 (en) * 2003-11-21 2005-06-16 Bayer Cropscience Ag Siylated carboxamides
DE102004005786A1 (en) * 2004-02-06 2005-08-25 Bayer Cropscience Ag Haloalkylcarboxamide
DE102004005785A1 (en) * 2004-02-06 2005-08-25 Bayer Cropscience Ag 2-Halogenfuryl / thienyl-3-carboxamide
CN101341136B (en) * 2005-12-22 2011-07-06 日本农药株式会社 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
TWI372752B (en) * 2005-12-22 2012-09-21 Nihon Nohyaku Co Ltd Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
AR105929A1 (en) 2015-09-07 2017-11-22 Bayer Cropscience Ag DERIVATIVES OF 2-DIFLUOROMETIL-NICOTIN (TIO) SUBSTITUTED CARBOXANILIDA AND ITS USE AS FUNGICIDES
KR20200040348A (en) 2018-10-08 2020-04-20 한국화학연구원 Thiophene Carboxamide Derivatives and Plant Disease Control Agents Containing the Same

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045554A (en) * 1988-11-29 1991-09-03 Monsanto Company Substituted thiazoles and their use as fungicides
US5223526A (en) * 1991-12-06 1993-06-29 Monsanto Company Pyrazole carboxanilide fungicides and use
US5330995A (en) * 1991-11-22 1994-07-19 Basf Aktiengesellschaft Anilide derivatives and their use for combating botrytis
US5416103A (en) * 1992-09-21 1995-05-16 Basf Aktiengesellschaft N-cyclohex(en)yl-pyridine carboxamides and compositions containing them for controlling fungal pests
US5438070A (en) * 1992-09-21 1995-08-01 Basf Aktiengesellschaft Carboxanilides, their preparation and compositions containing them for controlling harmful fungi
US5922732A (en) * 1995-05-24 1999-07-13 Zeneca Limited Bicyclic amines
US5968947A (en) * 1996-11-26 1999-10-19 Zeneca Limited Bicyclic amine derivatives
US6093726A (en) * 1996-11-26 2000-07-25 Zeneca Limited Bicyclic amine derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001311A1 (en) 1989-07-25 1991-02-07 Monsanto Company Substituted carboxanilidothiazoles and their use as fungicides
IN172842B (en) * 1990-05-17 1993-12-11 Boots Pharmaceuticals Limited
ES2093327T3 (en) * 1992-07-15 1996-12-16 Basf Ag SUBSTITUTED OXIMETERS, PROCEDURE FOR THEIR OBTAINING AND USE FOR THE FIGHT AGAINST PESTS AND FUNGI.
DE19735224A1 (en) * 1997-08-15 1999-02-18 Basf Ag New bi:phenyl-amide derivatives are active against wide range of phytopathogenic fungi
DE19840322A1 (en) * 1998-09-04 2000-03-09 Bayer Ag Pyrazole carboxanilides
US6992098B2 (en) * 2000-07-24 2006-01-31 Bayer Cropscience Ag Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms
WO2002008197A1 (en) * 2000-07-24 2002-01-31 Bayer Cropscience Ag Biphenyl carboxamides
EP1599460B1 (en) * 2003-02-14 2007-11-07 Bayer CropScience Aktiengesellschaft Oxathiin carboxamide

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5045554A (en) * 1988-11-29 1991-09-03 Monsanto Company Substituted thiazoles and their use as fungicides
US5330995A (en) * 1991-11-22 1994-07-19 Basf Aktiengesellschaft Anilide derivatives and their use for combating botrytis
US5480897A (en) * 1991-11-22 1996-01-02 Basf Aktiengesellschaft Anilide derivatives and their use for combating botrytis
US5556988A (en) * 1991-11-22 1996-09-17 Basf Aktiengesellschaft Anilide derivatives and their use for combating botrytis
US5589493A (en) * 1991-11-22 1996-12-31 Basf Aktiengesellschaft Anilide derivatives and their use for combating botrytis
US5223526A (en) * 1991-12-06 1993-06-29 Monsanto Company Pyrazole carboxanilide fungicides and use
US5416103A (en) * 1992-09-21 1995-05-16 Basf Aktiengesellschaft N-cyclohex(en)yl-pyridine carboxamides and compositions containing them for controlling fungal pests
US5438070A (en) * 1992-09-21 1995-08-01 Basf Aktiengesellschaft Carboxanilides, their preparation and compositions containing them for controlling harmful fungi
US5922732A (en) * 1995-05-24 1999-07-13 Zeneca Limited Bicyclic amines
US5968947A (en) * 1996-11-26 1999-10-19 Zeneca Limited Bicyclic amine derivatives
US6093726A (en) * 1996-11-26 2000-07-25 Zeneca Limited Bicyclic amine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9765034B2 (en) 2012-05-09 2017-09-19 Bayer Cropscience Ag 5-halogenopyrazole biphenylcarboxamides

Also Published As

Publication number Publication date
WO2004054982A1 (en) 2004-07-01
AU2003298156A1 (en) 2004-07-09
BR0317290A (en) 2005-11-08
JP2006515841A (en) 2006-06-08
US7728019B2 (en) 2010-06-01
CN100391947C (en) 2008-06-04
EP1572663A1 (en) 2005-09-14
JP4555085B2 (en) 2010-09-29
US20080085924A1 (en) 2008-04-10
CN1745067A (en) 2006-03-08
EP1572663B1 (en) 2013-03-20
DE10258314A1 (en) 2004-06-24
BR0317290B1 (en) 2014-07-01

Similar Documents

Publication Publication Date Title
US7329633B2 (en) Disubstituted pyrazolylcarboxanilides
US7358214B2 (en) Pyrazolyl carboxanilides for controlling unwanted microorganisms
DE102004022897A1 (en) Azinyl-imidazoazines
US20100216849A1 (en) Biphenylcarboxamides
US7868179B2 (en) Thiazolyl biphenyl amides
ZA200603103B (en) 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organism
ZA200503278B (en) Thiazol-(bi)cycloalkyl-carboxanilides
ZA200603101B (en) N-substituted pyrazolyl carboxanilides
US7732375B2 (en) Hexyl carboxanilides and their use for controlling fungi
JP4426308B2 (en) Bactericides based on biphenylbenzamide derivatives
US7208169B2 (en) Biphenyl carboxamides
US7598389B2 (en) Silylated carboxamides
US20060178513A1 (en) Pyridinylanilides
EP1501820B1 (en) Methylthiophene carboxanilides

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION